0001213900-21-043396.txt : 20210817 0001213900-21-043396.hdr.sgml : 20210817 20210817153306 ACCESSION NUMBER: 0001213900-21-043396 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 42 CONFORMED PERIOD OF REPORT: 20210531 FILED AS OF DATE: 20210817 DATE AS OF CHANGE: 20210817 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bespoke Extracts, Inc. CENTRAL INDEX KEY: 0001409197 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204743354 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-52759 FILM NUMBER: 211182609 BUSINESS ADDRESS: STREET 1: 323 SUNNY ISLES BOULEVARD STREET 2: SUITE 700 CITY: SUNNY ISLES STATE: FL ZIP: 33160 BUSINESS PHONE: 855-633-3738 MAIL ADDRESS: STREET 1: 323 SUNNY ISLES BOULEVARD STREET 2: SUITE 700 CITY: SUNNY ISLES STATE: FL ZIP: 33160 FORMER COMPANY: FORMER CONFORMED NAME: DiMi Telematics International, Inc. DATE OF NAME CHANGE: 20120319 FORMER COMPANY: FORMER CONFORMED NAME: FIRST QUANTUM VENTURES INC DATE OF NAME CHANGE: 20071106 FORMER COMPANY: FORMER CONFORMED NAME: First Quantum Ventures Inc DATE OF NAME CHANGE: 20070808 10-Q 1 f10q0521_bespoke.htm QUARTERLY REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: May 31, 2021

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________

 

Commission File Number: 000-52759

 

BESPOKE EXTRACTS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   20-4743354
(State or other jurisdiction 
of incorporation)
  (IRS Employer 
Identification No.)

 

323 Sunny Isles Boulevard, Suite 700

Sunny Isles Beach, FL 33160

(Address of principal executive offices)

 

855-633-3738

(Registrant’s telephone number, including area code)

 

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months, and (2) has been subject to such filing requirements for the past 90 days.  Yes  ☒   No  ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  ☒   No  ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐   No ☒

 

As of August 10, 2021, there were 246,889,621 shares outstanding of the registrant’s common stock, par value $0.001.

 

 

 

 

 

 

TABLE OF CONTENTS

 

      Page No. 
       
PART I - FINANCIAL INFORMATION   1
Item 1. Financial Statements   1
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   12
Item 3. Quantitative and Qualitative Disclosures About Market Risk   15
Item 4 Controls and Procedures   15
       
PART II - OTHER INFORMATION   16
Item 1. Legal Proceedings   16
Item 1A. Risk Factors   16
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   16
Item 3. Defaults Upon Senior Securities   16
Item 4. Mine Safety Disclosures   16
Item 5. Other Information   16
Item 6. Exhibits   16

 

i

 

 

PART I

 

Item 1. Financial Statements. 

 

Bespoke Extracts, Inc.

Condensed Balance Sheets

 

   May 31,   August 31, 
   2021   2020 
   (Unaudited)     
Assets        
Current assets        
Cash  $83,145   $126,603 
Accounts receivable, net   4,852    3,585 
Prepaid expense   92,000    2,319 
Inventory, net   76,857    - 
Total current assets   256,854    132,507 
           
Furniture and equipment   2,745    - 
Domain names, net of amortization of $13,305 and $10,872, respectively   33,558    33,741 
Total assets  $293,157   $166,248 
           
Liabilities and Stockholders’ Deficit          
Current liabilities          
Accounts payable and accrued liabilities  $62,136   $59,913 
Note payable - related party   534    120,000 
Convertible notes   500,000    500,000 
Total current liabilities   562,670    679,913 
           
Commitments and contingencies (Note 7)          
           
Stockholders’ Deficit          
Preferred stock, par value $0.001, 50,000,000 shares authorized, 1 share issued and outstanding as of May 31, 2021 and August 31, 2020, respectively   -    - 
Series A Convertible Preferred Stock, $0.001 par value, 1,000 designated shares; no shares issued and outstanding as of May 31, 2021 and August 31, 2020, respectively   -    - 
Series C Preferred Stock, $0.001 par value, 1 share designated;  1 share issued and outstanding as of May 31, 2021 and  August 31, 2020, respectively, stated value $24,000.   -    - 
Common stock, $0.001 par value: 3,000,000,000 shares authorized; 246,888,426  and 194,388,426 shares issued and outstanding as of May 31, 2021 and August 31, 2020, respectively   246,889    194,389 
Additional paid-in capital   19,066,135    17,992,635 
Common stock payable   -    76,000 
Accumulated deficit   (19,582,537)   (18,776,689)
Total stockholders’ deficit   (269,513)   (513,665)
Total liabilities and stockholders’ deficit  $293,157   $166,248 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

1

 

 

Bespoke Extracts, Inc.

Condensed Statements of Operations

(Unaudited)

 

   For the three months ended   For the nine months ended 
   May 31,   May 31,   May 31,   May 31, 
   2021   2020   2021   2020 
Sales  $10,117   $-   $21,684   $1,739 
Cost of products sold   3,186    -    7,202    1,087 
Gross Profit   6,931    -    14,482    652 
                     
Operating expenses:                    
Selling, general and administrative expenses   206,087    3,161,806    551,170    3,594,236 
Professional fees   22,604    25,367    85,227    174,153 
Consulting   77,000    24,562    181,500    158,062 
Amortization expense of domain name   811    811    2,433    2,797 
Total operating expenses   306,502    3,212,546    820,330    3,929,248 
                     
Loss from operations   (299,571)   (3,212,546)   (805,848)   (3,928,596)
                     
Other expense                    
Loss on settlement of debt   -    -    -    (89,595)
Interest expense and amortization of debt discount   -    (242,188)   -    (535,688)
Total other expense   -    (242,188)   -    (625,283)
                     
Loss before income tax   (299,571)   (3,454,734)   (805,848)   (4,553,879)
Provision for income tax   -    -    -    - 
Net Loss  $(299,571)  $(3,454,734)  $(805,848)  $(4,553,879)
                     
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING                    
Basic and Diluted   246,888,426    111,910,165    225,296,851    105,433,560 
                     
LOSS PER COMMON SHARE OUTSTANDING                    
Basic and Diluted  $(0.00)  $(0.03)  $(0.00)  $(0.04)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

2

 

 

Bespoke Extracts, Inc.

Condensed Statement of Stockholders Deficit

For The Three and Nine Months Ended May 31, 2021 and 2020

Unaudited

 

   Series A   Series B   Series C                         
   Preferred   Preferred   Preferred   Preferred   Preferred   Preferred   Common   Common       Common         
   Shares   Par   Shares   Par   Shares   Par   Shares   Par       Stock   Accumulated     
   Outstanding   Amount   Outstanding   Amount   Outstanding   Amount   Outstanding   Amount   APIC   Payable   Deficit   Total 
Balance February 29, 2020 (Unaudited)   -   $-    1   $1    -   $-    110,388,426   $110,389   $14,796,446   $76,000   $(15,235,028)  $(252,192)
                                                             
Options and warrant expense   -    -    -    -    -    -    -    -    3,150,855    -    -    3,150,855 
                                                             
Exercise of stock options   -    -    -    -    -    -    20,000,000    20,000    -    -    -    20,000 
                                                             
Exchange of preferred stock   -    -    (1)   (1)   1    -    -    -    1    -    -    - 
                                                             
Capital contribution of accrued salary -  related party   -    -    -    -    -    -    -    -    45,333    -    -    45,333 
                                                             
Net loss for the three months ended May 31, 2020   -    -    -    -    -    -    -    -    -    -    (3,454,734)   (3,454,734)
Balance May 31, 2020 (Unaudited)      $       $    1   $    130,388,426   $130,389   $17,992,635   $76,000   $(18,689,762)  $(490,738)

  

   Series A   Series C                         
   Preferred   Preferred   Preferred   Preferred   Common   Common       Common         
   Shares   Par   Shares   Par   Shares   Par       Stock   Accumulated     
   Outstanding   Amount   Outstanding   Amount   Outstanding   Amount   APIC   Payable   Deficit   Total 
Balance February 28, 2021 (Unaudited)      $    1   $-    246,888,426   $246,889   $19,066,135   $-   $(19,282,966)  $30,058 
                                                   
Net loss for the three months ended May 31, 2021   -    -    -    -    -    -    -    -    (299,571)   (299,571)
Balance May 31, 2021 (Unaudited)      $    1   $-    246,888,426   $246,889   $19,066,135   $-   $(19,582,537)  $(269,513)

 

   Series A  Series B    Series C                         
   Preferred   Preferred   Preferred   Preferred    Preferred   Preferred   Common   Common       Common         
   Shares   Par   Shares   Par    Shares   Par   Shares   Par       Stock   Accumulated     
   Outstanding   Amount   Outstanding   Amount    Outstanding   Amount   Outstanding   Amount   APIC   Payable   Deficit   Total 
                                                  
Balance  August 31, 2019      $       $    $   $    78,155,093   $78,156   $13,950,095   $76,000   $(14,135,883)  $(31,632)
                                                              
Preferred stock issued for the conversion of accrued salary   -    -    1    1     -    -    -    -    23,999    -    -    24,000 
                                                              
Sale of common stock   -    -    -    -               20,833,333    20,833    104,167    -    -    125,000 
                                                              
Common stock issued  for services   -    -    -    -     -    -    4,500,000    4,500    36,000    -    -    40,500 
                                                              
Option and warrant expense   -    -    -    -     -    -    -    -    3,467,440    -    -    3,467,440 
                                                              
Exercise of stock options   -    -    -    -     -    -    20,000,000    20,000    -    -    -    20,000 
                                                              
Common stock issued with debt   -    -    -    -               9,900,000    9,900    108,800    -    -    118,700 
                                                              
Repurchase of common stock   -    -    -    -     -    -    (3,000,000)   (3,000)   (24,500)   -    -    (27,500)
                                                              
Exchange of preferred stock   -    -    (1)   (1)    1    -    -    -    1    -    -    - 
                                                              
Capital contribution of accrued salary -  related party   -    -    -    -     -    -    -         45,333    -    -    45,333 
                                                              
Beneficial conversion feature   -    -    -    -     -    -    -    -    281,300    -    -    281,300 
                                                              
Net loss for the nine months ended May 31, 2020   -    -    -    -     -    -    -    -    -    -    (4,553,879)   (4,553,879)
                                                              
Balance  May 31, 2020 (Unaudited)      $       $     1   $    130,388,426   $130,389   $17,992,635   $76,000   $(18,689,762)  $(490,738)

 

   Series A   Series C                         
   Preferred   Preferred   Preferred   Preferred   Common   Common       Common         
   Shares   Par   Shares   Par   Shares   Par       Stock   Accumulated     
   Outstanding   Amount   Outstanding   Amount   Outstanding   Amount   APIC   Payable   Deficit   Total 
Balance August 31, 2020      $    1   $    194,388,426   $194,389   $17,992,635   $76,000   $(18,776,689)  $(513,665)
                                                   
Common stock for conversion of note payable - related party   -    -              20,000,000    20,000    230,000    -    -    250,000 
                                                   
Exchange of common stock payable   -    -    -    -    500,000    500    75,500    (76,000)   -    - 
                                                   
Sale of common stock                       32,000,000    32,000    768,000    -    -    800,000 
                                                   
Net loss for the nine months ended May 31, 2021   -    -    -    -    -    -    -    -    (805,848)   (805,848)
Balance  May 31, 2021 (Unaudited)      $    1   $    246,888,426   $246,889   $19,066,135   $-   $(19,582,537)  $(269,513)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

3

 

 

Bespoke Extracts, Inc.

Condensed Statements of Cash Flows

(Unaudited)

 

   For the nine months ended 
   May 31,   May 31, 
   2021   2020 
Cash flows from operating activities          
Net Loss  $(805,848)  $(4,553,879)
Adjustments to reconcile net loss to net cash used in operating activities          
Amortization and impairment expense of domain names   2,433    2,797 
Amortization of debt discounts   -    535,687 
Bad debt expense   -    2,981 
Loss on settlement of debt        89,595 
Option and warrant expense   -    3,467,440 
Common stock issued for services   -    40,500 
Changes in operating assets and liabilities:          
Accounts receivable   (1,267)   (165)
Inventory   (76,857)   1,907 
Prepaid expense   (89,681)   6,137 
Accounts payable and accrued liabilities   2,223    (542)
Net Cash used in operating activities   (968,997)   (407,542)
           
Cash flows from investing activities          
Purchase of  Url   (2,250)   - 
Purchase of  equipment   (2,745)   - 
Net cash used in investing activities   (4,995)   - 
           
Cash flow from financing activities          
Proceeds from note payable - related party   130,534    - 
Proceeds from the issuance of  convertible debt   -    400,000 
Proceeds from exercise of stock options for cash   -    20,000 
Repayment of debt   -    (120,000)
Repurchase of common stock   -    (27,500)
Sale of common stock   800,000    125,000 
Net cash provided by financing activities   930,534    397,500 
           
Net decrease in cash   (43,458)   (10,042)
Cash at beginning of period   126,603    10,343 
Cash at end of period  $83,145   $301 
           
Supplemental disclosure of cash flow information          
Cash paid for interest  $-   $- 
Cash paid for income taxes  $-   $- 
           
Noncash investing and financing activities:          
Discount due beneficial conversion feature  $-   $281,300 
Stock issued with convertible debt  $-   $118,700 
Stock issued for conversion of debt - related party  $250,000   $- 
Capital contribution of salary - related party  $        $45,333 
Stock issued for common stock payable  $76,000   $- 
Preferred stock issued for the conversion of accrued salary  $-   $24,000 
Assignment of URL for settlement of debt  $-   $5,282 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

4

 

 

NOTES TO CONDENSED FINANCIAL STATEMENTS

May 31, 2021 AND May 21, 2020

 (Unaudited)

 

1. NATURE OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN

 

Nature of Business Operations

 

Bespoke Extracts, Inc. (the “Company”) is a Nevada corporation focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products.

 

The Company introduced its original line of CBD products in 2018. In the fall of 2020, the Company unveiled a new brand image, new website and ecommerce store and a new line-up of hemp-derived CBD formulations available for purchase in the form of tinctures, softgels and creams.

 

Basis of Presentation

 

The accompanying condensed unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments consisting of a normal and recurring nature considered necessary for a fair presentation have been included. Operating results for the three and nine months ended May 31, 2021 may not necessarily be indicative of the results that may be expected for the year ended August 31, 2021.

 

For further information, refer to the Company’s financial statements and footnotes thereto included in the Annual Report on Form 10-K for the year ended August 31, 2020.

 

Certain prior period amounts have been reclassified to conform to the current period presentation.

 

Going Concern

 

The accompanying condensed financial statements have been prepared assuming a continuation of the Company as a going concern. The Company had negative cash flows from operations, a working capital deficit and an accumulated deficit as of and for the nine months ended May 31, 2021. This raises substantial doubt about our ability to continue as a going concern.

 

The Company’s ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repaying its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed.

 

Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we will have to curtail or cease our operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. These financial statements do not include any adjustments that might arise from this uncertainty.

 

 Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements and accompanying notes. Significant estimates include the assumption used in the valuation of equity-based transactions, valuation of intangible assets, allowance for doubtful accounts and inventory valuation and reserves. Actual results could differ from those estimates. 

 

5

 

 

Cash and Cash Equivalents

 

Cash and cash equivalents include all highly liquid investments with original maturities of three months or less at the time of purchase. At May 31, 2021 and August 31, 2020, the Company did not have any cash equivalents.

 

Fair Value of Financial Instruments

 

The carrying amounts of cash, accounts receivable, prepaid expenses, inventory and other assets, accounts payable, accrued liabilities, note payable and convertible note payable approximate their fair values as of May 31, 2021 and August 31, 2020, respectively, because of their short-term natures and the Company’s borrowing rate of interest.

 

Accounts Receivable

 

Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased bad debt expense.

 

The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30 or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging off uncollectible receivables is made. At May 31, 2021 and August 31, 2020, the Company has recorded an allowance for doubtful accounts of $2,981 and $2,981, respectively. At May 31, 2021 and August 31, 2020 included in the accounts receivable is the merchant holdback receivable balance of $3,636 and $3,585, respectively which will be remitted to the Company in the future.

 

Inventory

 

Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of May 31, 2021 and August 31, 2020, inventory amounted to $76,857 and $0, respectively, which consisted of finished goods of $72,435, and raw materials of $4,422 net of reserves. During the nine months ended May 31, 2021 the Company adjusted the reserves by $6,776 for products sold. As of May 31, 2021 and August 31, 2020 inventory reserves were $33,476 and $40,252, respectively.

 

Revenue Recognition

 

We account for revenue in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification Topic 606, “Revenue from Contracts with Customers”. Revenue is measured based on the amount of consideration that we expect to receive, reduced by discounts and estimates for credits and returns (calculated based upon previous experience and management’s evaluation). Outbound shipping charged to customers is recognized at the time the related merchandise revenues are recognized and are included in net revenues. Inbound and outbound shipping and delivery costs are included in cost of revenues.

 

Our products are sold through our online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due on the date of shipment. The Company offers a 30 day return policy on sales.

 

6

 

 

Stock Option Plans

 

Stock options and warrants issued to consultants and other non-employees as compensation for services provided to the Company are accounted for based on the fair value of the services provided or the estimated fair market value of the option or warrant, whichever is more reliably measurable, and in accordance FASB ASC 718, Compensation-Stock Compensation, including related amendments and interpretations. The related expense is recognized over the period the services are provided. Stock option compensation expense has been recognized as a component of general and administrative expenses in the accompanying financial statements for the three and nine months ended May 31, 2020. No stock option compensation expense was recognized for the three and nine months ended May 31, 2021.

 

Net Income / (Loss) per Share

 

Basic income / (loss) per share amounts are computed based on net income / (loss) divided by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if potentially dilutive securities were exercised or converted to common stock. The dilutive effect of options and warrants and their equivalent is computed by application of the treasury stock method and the effect of convertible securities by the “if converted” method. The effect of 3,000,000 warrants and 0 options as well as 500,000,000 shares issuable upon the conversion of a convertible note are anti-dilutive for the three and nine months ended May 31, 2021. The effect of 3,450,000 warrants and 81,200,000 options is anti-dilutive for the three and nine months end May 31, 2020.  

 

2. ASSET PURCHASE AGREEMENT

 

On February 21, 2017, the Company purchased all right, title, interest and goodwill in or associated with certain domain names set forth in an asset purchase agreement for a total of $20,185 in cash and 200,000 shares of the Company’s common stock valued at $30,000. During the year ended August 31, 2020, the Company transferred certain URLs valued at $5,282 to an unrelated party and impaired $289 leaving a balance of $44,614 of URL’s. The domain names are being amortized over a 15 year period. During the three and nine months ended May 31, 2021, the Company recorded an amortization expense of $811 and $2,433, respectively. During the nine months ended May 31, 2020, the Company recorded an impairment expense of $289 for the expired domain names. During the three and nine months ended May 31, 2020, the Company recorded an amortization expense of $811 and $2,508 respectively.

 

3. NOTE PAYABLE - RELATED PARTY

 

On August 31, 2020, the Company issued a promissory note in the principal amount of $150,000, to Danil Pollack, the Company’s chief executive officer. $120,000 was remitted upon execution of the note and the remaining $30,000 was remitted on September 22, 2020. The note did not bear interest. On November 10, 2020, the Company entered into an exchange agreement with Mr. Pollack. Pursuant to the exchange agreement, Mr. Pollack exchanged the note for 15,000,000 shares of common stock of the Company.

 

During the nine months ended May 31, 2021, Mr. Pollack loaned the Company an additional $100,534 that was non-interest bearing and payable upon demand. $100,000 of this amount was subsequently deemed to be consideration for 5,000,000 shares of common stock the Company issued to Mr. Pollack on January 6, 2021.

 

4. CONVERTIBLE NOTE PAYABLE

 

On December 24, 2019, the Company entered into and closed a securities purchase agreement with an accredited investor, pursuant to which the Company issued and sold to the investor an original issue discount convertible debenture in the principal amount of $500,000, for a purchase price of $300,000. The Company also issued to the investor 5,000,000 shares of common stock valued at $55,000 ($0.005 per share). The Company recorded beneficial conversion of $245,000 due to the conversion feature. The debenture may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock. The debenture had an original maturity date of April 30, 2020 and was convertible into shares of common stock of the Company at an initial conversion price of $0.001, except that, if the Company failed to repay the debenture upon maturity, the conversion price would be reduced to $0.0004 (subject to adjustment for stock splits, stock dividends, and similar transactions) and the debenture would bear interest at the rate of 9% per year. The Company’s obligation to repay the debenture upon maturity was initially secured by a security interest in the Company’s inventory pursuant to a security agreement between the Company and the investor. For the year ended August 31, 2020 the Company recorded amortization of debt discount of $500,000. A portion of the debenture was subsequently sold by the original purchaser to a third party. On April 23, 2020, the Company entered into an amendment to the security agreement with the holders of the debentures. Pursuant to the security agreement amendment, the collateral under the security agreement was amended to be the Company’s URLs. The Company has also entered into five amendments to the debentures to extend the maturity date, including, most recently, an amendment entered into on August 2, 2021, to extend the maturity date to August 31, 2021.

 

7

 

 

5. EQUITY

 

Common Stock and Preferred Stock

 

As of August 31, 2020, the Company had authorized capital of 800,000,000 shares of common stock with a par value of $0.001, and 50,000,000 shares of preferred stock with a par value of $0.001. On October 2, 2020, the Company filed a certificate of amendment to the Company’s articles of incorporation with the Secretary of State of Nevada, pursuant to which the Company increased its authorized shares of common stock from 800,000,000 to 3,000,000,000. 1,000 shares of preferred stock are designated as Series A Convertible Preferred Stock. No shares of Series A Preferred Stock are issued and outstanding as of August 31, 2020 and May 31, 2021 respectively. The Company’s Certificate of Designation of Series B Preferred Stock was withdrawn by the Company on June 30, 2020. 1 share of preferred stock is designated Series C Preferred Stock and is issued and outstanding as of August 31, 2020 and May 31, 2021, respectively. The Series C Preferred Stock has a stated value of $24,000 and entitles the holder to 51% of the total voting power of the Company’s stockholders. The Company may, in its sole discretion, redeem the Series C Preferred Stock at any time for a redemption price equal to the stated value. Upon payment of the redemption price by the Company, the Series C Preferred Stock will revert to the status of authorized but unissued preferred stock.

 

Pursuant to a securities purchase agreement entered into on June 6, 2018 the Company was obligated to issue additional shares of common stock if the Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser would be equal to $50,000 divided by lower financing price. As of August 31, 2020, the Company was obligated to issue 500,000 shares of common stock valued at $76,000. On January 5, 2021, the Company issued the 500,000 shares of common stock.

 

On August 31, 2020, the Company issued a promissory note in the principal amount of $150,000, to Danil Pollack, the Company’s chief executive officer. $120,000 was remitted upon execution of the note and the remaining $30,000 was remitted on September 22, 2020. The note did not bear interest. On November 10, 2020, the Company entered into an exchange agreement with Mr. Pollack. Pursuant to the exchange agreement, Mr. Pollack exchanged the promissory note for 15,000,000 shares of common stock of the Company.

 

During the nine months ended May 31, 2021, Mr. Pollack loaned the Company an additional $100,534 that was non-interest bearing and payable upon demand. $100,000 of this amount was subsequently deemed to be consideration for 5,000,000 shares of common stock the Company issued to Mr. Pollack on January 6, 2021.

 

On November 30, 2020, the Company entered into a securities purchase agreement with Danil Pollack. Pursuant to the purchase agreement, the Company issued and sold to Mr. Pollack 20,000,000 shares of common stock for an aggregate purchase price of $200,000.

 

On January 21, 2021, the Company entered into a securities purchase agreement with Danil Pollack. Pursuant to the purchase agreement, the Company issued and sold to Mr. Pollack 2,000,000 shares of common stock for an aggregate purchase price of $100,000.

 

On February 24, 2021, the Company entered into a securities purchase agreement with an accredited investor. Pursuant to the purchase agreement, the Company issued and sold to the investor 10,000,000 shares of common stock for an aggregate purchase price of $500,000.

 

8

 

 

Warrants 

 

The following table summarizes the warrant activities during the nine months ended May 31, 2021:

 

   Number of
Warrants
   Weighted-
Average
Price Per
Share
   Weighted-
Average
Remaining
Life
 
Outstanding at August 31, 2020   3,450,000   $0.56   2.8 years 
Granted   -    -     
Canceled or expired   (450,000)   0.81     
Exercised   -    -     
Outstanding at May 31, 2021   3,000,000   $0.52   2.41 years 
Exercisable at May 31, 2021   3,000,000   $0.52   2.41 years 
Intrinsic value at May 31, 2021       $-     

 

Options

 

On April 21, 2020, Danil Pollack was appointed president, chief executive officer, and chief financial officer of the Company. In connection with Mr. Pollack’s appointment, the Company entered into an employment agreement with Mr. Pollack. Pursuant to the employment agreement, Mr. Pollack will serve as the Company’s chief executive officer and president for a period of one year, which term will renew automatically for successive one year terms, subject to the right of either party to terminate the agreement at any time upon written notice. Mr. Pollack was granted the right, for a period of six months, to purchase up to 100,000,000 shares of common stock of the Company for a purchase price of $0.001 per share. The Company recognized option expense of $1,416,975 during the year ended August 31, 2020. During the year ended August 31, 2020, Mr. Pollack exercised 84,000,000 stock options for $84,000. During the nine months ended May 31, 2021, the remaining 16,000,000 stock options expired.

 

The following table summarizes the option activities during the nine months ended May 31, 2021:

 

   Number of
Options
   Weighted-
Average
Price Per
Share
   Weighted-
Average
Remaining
Life
 
Outstanding at August 31, 2020   16,000,000   $.001   0.9 years 
Granted   -    -     
Canceled or expired   (16,000,000)   .001     
Exercised   -    -     
Outstanding at May 31, 2021   -   $-     
Exercisable at May 31, 2021   -   $-     

  

6. RELATED PARTY TRANSACTIONS

 

On September 30, 2020, the Company entered into an amendment to the Company’s employment agreement, dated April 22, 2020, with Danil Pollack, the Company’s chief executive officer. Pursuant to the amendment, the Company will pay Mr. Pollack an annual salary of $48,000. The Company may also in its discretion pay additional compensation to Mr. Pollack at any time as a bonus. On April 27, 2021, the Company entered into an amendment to the Company’s employment agreement with Mr. Pollack. Pursuant to the amendment, the Company will pay Mr. Pollack an annual salary of $66,000 effective April 1, 2021. The Company may also in its discretion pay additional compensation to Mr. Pollack at any time as a bonus.

 

On August 31, 2020, the Company issued a promissory note in the principal amount of $150,000, to Danil Pollack. $120,000 was remitted upon execution of the note and the remaining $30,000 was paid on September 22, 2020. The note did not bear interest. On November 10, 2020, the Company entered into an exchange agreement with Mr. Pollack. Pursuant to the exchange agreement, Mr. Pollack exchanged this note for 15,000,000 shares of common stock of the Company.

 

9

 

 

During the nine months ended May 31, 2021, Mr. Pollack loaned the Company an additional $100,534 that was non-interest bearing and payable upon demand. $100,000 of this amount was subsequently deemed to be consideration for 5,000,000 shares of common stock the Company issued to Mr. Pollack on January 6, 2021.

 

On November 30, 2020, the Company entered into a securities purchase agreement with Mr. Pollack. Pursuant to the purchase agreement, the Company issued and sold to Mr. Pollack 20,000,000 shares of common stock for an aggregate purchase price of $200,000.

 

On January 21, 2021, the Company entered into a securities purchase agreement with Danil Pollack. Pursuant to the purchase agreement, the Company issued and sold to Mr. Pollack 2,000,000 shares of common stock for an aggregate purchase price of $100,000.

 

7. COMMITMENTS AND CONTINGENCIES

 

Pursuant to a securities purchase agreement entered into on June 6, 2018 the Company was obligated to issue additional shares of common stock if the Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser would be equal to $50,000 divided by lower financing price. As of November 30, 2020 and August 31, 2020, the Company was obligated to issue 500,000 shares of common stock valued at $76,000 which is included in the common stock payable in the accompanying balance sheet. On January 5, 2021, the Company issued 500,000 shares of common stock.

 

On April 21, 2020, Danil Pollack was appointed president, chief executive officer, and chief financial officer of the Company. In connection with Mr. Pollack’s appointment, the Company entered into an employment agreement with Mr. Pollack. On September 30, 2020, the Company entered into an amendment to the employment agreement. Pursuant to the amendment, the Company will pay Mr. Pollack an annual salary of $48,000. The Company may also in its discretion pay additional compensation to Mr. Pollack at any time as a bonus. On April 27, 2021, the Company entered into an amendment to the Company’s employment agreement with Mr. Pollack. Pursuant to the amendment, the Company will pay Mr. Pollack an annual salary of $66,000 effective April 1, 2021. The Company may also in its discretion pay additional compensation to Mr. Pollack at any time as a bonus.

 

On October 13, 2020, the Company entered into a consulting agreement with Yaniv Rozen pursuant to which the Company engaged Mr. Rozen to serve as the Company’s chief operating officer on a consultant/independent contractor basis. Mr. Rozen was permitted to engage in other business activities while serving as the Company’s chief operating officer. On July 1, 2021, Yaniv Rozen resigned as chief operating officer of the Company.

 

Pursuant to the consulting agreement, the Company agreed to pay Mr. Rozen a fee of $3,000 per month.

 

The Company also agreed to issue to Mr. Rozen shares of common stock, and increase such monthly fee, as follows:

 

  Within five business day of the end of the fourth quarter of 2020, (i) if the Company’s average sales were at least $50,000 per month, for such quarter, the Company would issue to Mr. Rozen 500,000 shares of common stock; or (ii) if the Company’s average sales were at least $100,000 per month for such quarter, the Company would issue to Mr. Rozen 750,000 shares of common stock;

 

  Within five business day of the end of the first quarter of 2021, (i) if the Company’s average sales were at least $100,000 per month for such quarter, the Company would issue to Mr. Rozen 750,000 shares of common stock, or (ii) if the Company’s average sales were at least $150,000 per month for such quarter, the Company would issue to Mr. Rozen 1,000,000 shares of common stock, and would increase Mr. Rozen’s fee to $5,000 per month effective commencing at the end such quarter;

 

10

 

 

  Within five business days of the end of the second quarter of 2021, (i) if the Company’s average sales were at least $200,000 per month, for such quarter, the Company would issue to Mr. Rozen 1,500,000 shares of common stock, or (ii) if the Company’s average sales were at least $300,000 per month, for such quarter, the Company would issue to Mr. Rozen 2,000,000 shares of common stock; and

 

  Within five business days of the end of the third quarter of 2021, (i) if the Company’s average sales were at least $300,000 per month, for such quarter, the Company would issue to Mr. Rozen 2,000,000 shares of common stock; or (ii) if the Company’s average sales were at least $500,000 per month, for such quarter, the Company would issue to Mr. Rozen 3,000,000 shares of common stock, and would increase Mr. Rozen’s fee to $7,000 per month effective commencing at the end such quarter.

 

As of July 1, 2021, Mr. Rozen’s resignation date, there was no common stock owed to Mr. Rozen as the quarterly target sales were not met.

 

The COVID-19 pandemic may negatively affect our operations, including by limiting access to our facilities, customers, management, and professional advisors, and causing delays and constraints in manufacturing and shipping of our products. These factors, in turn, may negatively impact our operations, financial condition and demand for our products, and our ability to raise capital on acceptable terms, or at all.

 

8. MAJOR CUSTOMERS

 

At May 31, 2021 and August 31, 2020, no individual customer amounted to over 10% of total accounts receivable. During the three and nine months ended May 31, 2021 and May 31, 2020 no individual customer amounted to over 10% of total sales. 

 

9. SUBSEQUENT EVENTS 

 

On July 1, 2021, Yaniv Rozen resigned as chief operating officer of the Company. See Note 7.

 

On August 2, 2021, the Company entered into amendments (“Amendment No. 6”) with the holders of the Company’s original issue discount convertible debentures, with an original issuance date of December 24, 2019, as amended by amendment No. 1 thereto, dated May 28, 2020, amendment No. 2 thereto, dated August 21, 2020, amendment No. 3 thereto, dated December 10, 2020, Amendment No. 4 thereto, dated January 15, 2021, and Amendment No. 5 thereto, dated April 2, 2021, in the aggregate outstanding principal amount of $500,000. Pursuant to Amendment No. 6, the maturity date of the debentures was extended to August 31, 2021.

 

11

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

We and our representatives may from time to time make written or oral statements that are “forward-looking,” including statements contained in this Quarterly Report and other filings with the SEC, reports to our stockholders and news releases. All statements that express expectations, estimates, forecasts or projections are forward-looking statements. In addition, other written or oral statements which constitute forward-looking statements may be made by us or on our behalf. Words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “estimate,” “project,” “forecast,” “may,” “should,” and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in or suggested by such forward-looking statements. We undertake no obligation to update or revise any of the forward-looking statements after the date of this Quarterly Report to conform forward-looking statements to actual results, except as may be required under applicable law. Important factors on which such statements are based are assumptions concerning uncertainties, including but not limited to, uncertainties associated with the following:

 

  Inadequate capital and barriers to raising the additional capital or to obtaining the financing needed to implement our business plans;

 

  Our failure to earn revenues or profits;

 

  Inadequate capital to continue business;

 

  Volatility, lack of liquidity or decline of our stock price;

 

  Potential fluctuation in quarterly results;

 

  Rapid and significant changes in markets;

 

  Insufficient revenues to cover operating costs; and

 

  The effect of the COVID-19 pandemic on our operations, including as it may limit access to our facilities, customers, management, and professional advisors, and negatively impact demand for our products, and ability to raise capital on acceptable terms or at all.  

 

The following discussion should be read in conjunction with the financial statements and the notes thereto which are included in this Quarterly Report.

  

Overview

 

The Company sells a proprietary line of specially-formulated, premium quality, hemp-derived CBD products direct to consumers through our ecommerce store, found at www.bespokeextracts.com. The Company introduced its original line of CBD products in 2018. In the fall of 2020, we unveiled a new brand image, new website and ecommerce store and a new line-up of hemp-derived CBD formulations available for purchase in the form of tinctures, softgels and creams.

 

Results of Operations for the three months ended May 31, 2021 and May 31, 2020

 

Sales

 

Sales during the three months ended May 31, 2021 were $10,117 compared to $0 for the three months ended May 31, 2020. The increase in sales was primarily a result of increased marketing of the Company’s new line-up of hemp-derived CBD products and the sale of older products at reduced prices.

 

12

 

 

Operating Expenses

 

Selling, general and administrative expenses for the three months ended May 31, 2021 and May 31, 2020 were $206,087 and $3,161,806, respectively. Included in selling, general and administrative expenses, option and warrant expense for the three months ended May 31, 2021 and May 31, 2020 was $0 and $3,150,855, respectively which was primarily due to the fair value re-measurement of warrants and options, and the issuance of options to our President and CEO. Professional fees were $22,604 and $25,367, respectively for the three months ended May 31, 2021 and May 31, 2020, respectively. The decrease was due to reduced legal and accounting fees as the Company streamlined operations. Consulting expense was $77,000 and $24,562, respectively for the three months ended May 31, 2021 and May 31, 2020, respectively. The increase was primarily due to additional consulting agreements for sales and marketing during the three months ended May 31, 2021. Amortization expense of domain names for the three months ended May 31, 2021 and May 31, 2020 was $811 and $811 respectively.

 

Interest Expense and Amortization of Debt Discount

 

Interest expense on promissory notes for the three months ended May 31, 2021 and May 31, 2020 was $0 and $242,188, respectively. The decrease in interest expense was due to the amortization expense for the warrants and beneficial conversion associated with those notes that had been converted to common stock or fully amortized during the three months ended May 31, 2020.

 

Net Loss

 

For the reasons stated above, our net loss for the three months ended May 31, 2021 was $299,571, or $0.00 per share, compared to a net loss for the three months ended May 31, 2020 of $3,454,734, or $0.03 per share.

 

Results of Operations for the nine months ended May 31, 2021 and May 31, 2020

 

Sales

 

Sales during the nine months ended May 31, 2021 were $21,684 compared to $1,739 for the nine months ended May 31, 2020. The increase in sales was primarily a result of increased marketing of the Company’s new line-up of hemp-derived CBD products and sales of older products at reduced prices.

 

Operating Expenses

 

Selling, general and administrative expenses for the nine months ended May 31, 2021 and May 31, 2020 were $551,170 and $3,594,236, respectively. Included in selling, general and administrative expenses, option and warrant expense for the nine months ended May 31, 2021 and May 31, 2020 was $0 and $3,467,440, respectively which was primarily due to the fair value re-measurement of warrants and options, and the issuance of options to our President and CEO. Stock-based compensation for the nine months ended May 31, 2021 and May 31, 2020 were $0 and $40,500, respectively which was a result of common stock issued for services. Professional fees were $85,227 and $174,153, respectively for the nine months ended May 31, 2021 and May 31, 2020, respectively. The decrease in expenses was due to reduced legal and accounting fees as the Company streamlined operations. Consulting expense was $181,500 and $158,062, for the nine months ended May 31, 2021 and May 31, 2020, respectively. The increase was primarily due to additional consulting agreements for sales and marketing during the nine months ended May 31, 2021. Amortization expense of domain names for the nine months ended May 31, 2021 and May 31, 2020 was $2,433 and $2,508, respectively.

 

Loss on settlement of debt

 

On December 24, 2019, the Company entered into an agreement (the “Repayment Agreement”) with the holder of the amended and restated original issue discount convertible debenture issued by the Company on November 11, 2019, in the original principal amount of $200,000 (the “November 2019 Debenture”). Pursuant to the Repayment Agreement, the Company paid the holder $120,000, and transferred certain URLs valued at $5,282 to the holder, and the November 2019 Debenture was deemed paid in full. The Company recognized a loss on settlement of debt of $89,595 during the nine months ended May 31, 2020.

 

13

 

 

Interest Expense and Amortization of Debt Discount

 

Interest expense on promissory notes for the nine months ended May 31, 2021 and May 31, 2020 was $0 and $535,688 respectively. The decrease in interest expense was due to the amortization expense for the warrants and beneficial conversion associated with those notes that had been converted to common stock or fully amortized during the nine months ended May 31, 2020.

 

Net Loss

 

For the reasons stated above, our net loss for the nine months ended May 31, 2021 was $805,848, or $0.00 per share, compared to a net loss for the nine months ended May 31, 2020 of $4,553,879, or $0.04 per share. 

 

Liquidity and Capital Resources

 

As of May 31, 2021, we had cash of $83,145. Net cash used in operating activities for the nine months ended May 31, 2021 was $968,997. Our current liabilities as of May 31, 2021 were $562,670 and consisted of accounts payable and accrued liabilities of $62,136, notes payable- related party of $534 and a convertible note payable of $500,000. As of August 31, 2020, we had cash of $126,603. Net cash used in operating activities for the nine months ended May 31, 2020 was $407,542. The increase in net cash used in operating activities during the nine months ended May 31, 2021 compared to May 31, 2020 was a result of the Company purchasing new inventory and an increase in prepaid expenses, partially offset by the increase in accounts payable and accrued liabilities.

   

During the nine months ended May 31, 2021, the Company raised $800,000 from the sale of common stock. During the nine months ended May 31, 2021 the Company received a total of $130,534 of loans from our Chief Executive Officer. During the nine months ended May 31, 2020, the Company raised $125,000 from the sale of common stock. During the nine months ended May 31, 2020, the Company received a total of $400,000, net of original issue discounts, from the sale of a convertible note and repaid $120,000. During the nine month ended May 31, 2020 the Company repurchased $27,500 of common stock and received $20,000 from the exercise of stock options.

 

The unaudited condensed financial statements included in this report have been prepared assuming a continuation of the Company as a going concern. The Company had negative cash flows from operations for the nine months ended May 31, 2021 and the year ended August 31, 2020 and had a working capital deficit at May 31, 2021 and August 31, 2020. This raises substantial doubt about our ability to continue as a going concern.

 

We have not generated positive cash flows from operating activities. Our primary source of capital has been from the sale of equity and convertible debt securities. Our primary use of capital has been for professional fees and selling, general and administrative costs. We have no committed sources of capital and will need to raise additional capital to continue and expand our operations. Additional capital may not be available on terms acceptable to us, or at all.

 

In addition, the COVID-19 pandemic may negatively affect our operations, including by limiting access to our facilities, customers, management, and professional advisors, and by causing delays and constraints in manufacturing and shipping of our products. These factors, in turn, may negatively impact our operations, financial condition and demand for our products, and our ability to raise capital on acceptable terms, or at all.

  

Off-Balance Sheet Arrangements

 

We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

14

 

 

Critical accounting policies and estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses during the reported periods. The more critical accounting estimates include estimates related to revenue recognition and accounts receivable allowances. We also have other key accounting policies, which involve the use of estimates, judgments and assumptions that are significant to understanding our results, which are described in Note 1 to our unaudited condensed financial statements appearing elsewhere in this report.   

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Not required for smaller reporting companies.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Management of the Company conducted an evaluation of the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rule 13a-15(e) and Rule 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. The Company’s disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms, and (ii) accumulated and communicated to our management, including our chief executive officer and chief financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Based on this evaluation, our management has concluded that the design and operation of our disclosure controls and procedures are not effective since the following material weaknesses exist:

 

  Our chief executive officer also functions as our chief financial officer. As a result, our officer may not be able to identify errors and irregularities in the financial statements and reports;

 

  We were unable to maintain full segregation of duties within our financial operations due to our reliance on limited personnel in the finance function. While this control deficiency did not result in any audit adjustments to our financial statements, it could have resulted in a material misstatement that might have been prevented or detected by a segregation of duties; and

 

  Documentation of all proper accounting procedures is not yet complete.

 

To the extent reasonably possible given our limited resources, we intend to take measures to cure the aforementioned weaknesses, including, but not limited to, increasing the capacity of our qualified financial personnel to ensure that accounting policies and procedures are consistent across the organization and that we have adequate control over financial statement disclosures.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting that occurred during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

15

 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

We are not currently a party to, nor are any of our property currently the subject of, any material legal proceedings. 

 

Item 1A. Risk Factors.

 

Not required for smaller reporting companies. 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

No disclosure required. 

 

Item 5. Other Information.

 

None.

 

Item 6. Exhibits.

  

Exhibit No.   Description
     
31.1   Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32.1   Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
101.INS   XBRL Instance Document*
101.SCH   XBRL Taxonomy Extension Schema Document*
101.CAL   XBRL Taxonomy Calculation Linkbase Document*
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB   XBRL Taxonomy Label Linkbase Document*
101.PRE   XBRL Taxonomy Presentation Linkbase Document*

 

  * Filed herewith.
  ** Furnished herewith.

 

16

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  BESPOKE EXTRACTS, INC.
     
Dated: August 17, 2021 By: /s/ Danil Pollack
   

Danil Pollack

Chief Executive Officer and Chief Financial Officer

    (Principal Executive Officer,
Principal Financial Officer and
Principal Accounting Officer)

 

 

17

 

 

EX-31.1 2 f10q0521ex31-1_bespoke.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Danil Pollack, certify that:

 

1)I have reviewed this Quarterly Report on Form 10-Q of Bespoke Extracts, Inc. (the “registrant”);

 

2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;

 

3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report;

 

4)The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5)The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

  /s/ Danil Pollack
  Danil Pollack
  Chief Executive Officer and Chief Financial Officer (Principal Executive
Officer and Principal Financial Officer)
   
  August 17, 2021
EX-32.1 3 f10q0521ex32-1_bespoke.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Bespoke Extracts, Inc., as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Danil Pollack, the Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)The information contained in such Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Danil Pollack  
Danil Pollack  
Chief Executive Officer and Chief Financial Officer  
(Principal Executive Officer and Principal Financial Officer)  
   
Dated:  August 17, 2021  
EX-101.INS 4 bspk-20210531.xml XBRL INSTANCE FILE 0001409197 2020-09-01 2021-05-31 0001409197 2021-08-10 0001409197 2021-05-31 0001409197 2020-08-31 0001409197 us-gaap:SeriesAPreferredStockMember 2021-05-31 0001409197 us-gaap:SeriesAPreferredStockMember 2020-08-31 0001409197 us-gaap:SeriesCPreferredStockMember 2021-05-31 0001409197 us-gaap:SeriesCPreferredStockMember 2020-08-31 0001409197 2021-03-01 2021-05-31 0001409197 2020-03-01 2020-05-31 0001409197 2019-09-01 2020-05-31 0001409197 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-02-29 0001409197 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2020-02-29 0001409197 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-02-29 0001409197 us-gaap:CommonStockMember 2020-02-29 0001409197 us-gaap:AdditionalPaidInCapitalMember 2020-02-29 0001409197 bspk:CommonStockPayableMember 2020-02-29 0001409197 us-gaap:RetainedEarningsMember 2020-02-29 0001409197 2020-02-29 0001409197 us-gaap:AdditionalPaidInCapitalMember 2020-03-01 2020-05-31 0001409197 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-03-01 2020-05-31 0001409197 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2020-03-01 2020-05-31 0001409197 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-03-01 2020-05-31 0001409197 us-gaap:CommonStockMember 2020-03-01 2020-05-31 0001409197 bspk:CommonStockPayableMember 2020-03-01 2020-05-31 0001409197 us-gaap:RetainedEarningsMember 2020-03-01 2020-05-31 0001409197 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-05-31 0001409197 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2020-05-31 0001409197 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-05-31 0001409197 us-gaap:CommonStockMember 2020-05-31 0001409197 us-gaap:AdditionalPaidInCapitalMember 2020-05-31 0001409197 bspk:CommonStockPayableMember 2020-05-31 0001409197 us-gaap:RetainedEarningsMember 2020-05-31 0001409197 2020-05-31 0001409197 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-02-28 0001409197 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-02-28 0001409197 us-gaap:CommonStockMember 2021-02-28 0001409197 us-gaap:AdditionalPaidInCapitalMember 2021-02-28 0001409197 bspk:CommonStockPayableMember 2021-02-28 0001409197 us-gaap:RetainedEarningsMember 2021-02-28 0001409197 2021-02-28 0001409197 us-gaap:RetainedEarningsMember 2021-03-01 2021-05-31 0001409197 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-05-31 0001409197 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-05-31 0001409197 us-gaap:CommonStockMember 2021-05-31 0001409197 us-gaap:AdditionalPaidInCapitalMember 2021-05-31 0001409197 bspk:CommonStockPayableMember 2021-05-31 0001409197 us-gaap:RetainedEarningsMember 2021-05-31 0001409197 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2019-08-31 0001409197 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2019-08-31 0001409197 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2019-08-31 0001409197 us-gaap:CommonStockMember 2019-08-31 0001409197 us-gaap:AdditionalPaidInCapitalMember 2019-08-31 0001409197 bspk:CommonStockPayableMember 2019-08-31 0001409197 us-gaap:RetainedEarningsMember 2019-08-31 0001409197 2019-08-31 0001409197 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2019-09-01 2020-05-31 0001409197 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2019-09-01 2020-05-31 0001409197 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2019-09-01 2020-05-31 0001409197 us-gaap:CommonStockMember 2019-09-01 2020-05-31 0001409197 us-gaap:AdditionalPaidInCapitalMember 2019-09-01 2020-05-31 0001409197 us-gaap:RetainedEarningsMember 2019-09-01 2020-05-31 0001409197 bspk:CommonStockPayableMember 2019-09-01 2020-05-31 0001409197 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-08-31 0001409197 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-08-31 0001409197 us-gaap:CommonStockMember 2020-08-31 0001409197 us-gaap:AdditionalPaidInCapitalMember 2020-08-31 0001409197 bspk:CommonStockPayableMember 2020-08-31 0001409197 us-gaap:RetainedEarningsMember 2020-08-31 0001409197 us-gaap:CommonStockMember 2020-09-01 2021-05-31 0001409197 us-gaap:AdditionalPaidInCapitalMember 2020-09-01 2021-05-31 0001409197 us-gaap:RetainedEarningsMember 2020-09-01 2021-05-31 0001409197 bspk:CommonStockPayableMember 2020-09-01 2021-05-31 0001409197 2019-09-01 2020-08-31 0001409197 2021-08-31 0001409197 us-gaap:WarrantMember 2021-03-01 2021-05-31 0001409197 bspk:OptionsMember 2020-09-01 2021-05-31 0001409197 2017-02-21 0001409197 2021-01-01 2021-01-06 0001409197 2021-01-06 0001409197 2019-12-24 0001409197 us-gaap:InvestorMember 2019-12-01 2019-12-24 0001409197 2019-12-01 2019-12-24 0001409197 bspk:SecuritiesPurchaseAgreementMember 2019-09-01 2020-08-31 0001409197 2020-09-20 2020-10-02 0001409197 us-gaap:SeriesCPreferredStockMember 2020-09-01 2021-05-31 0001409197 bspk:SecuritiesPurchaseAgreementMember us-gaap:InvestorMember 2018-06-01 2018-06-06 0001409197 us-gaap:SeriesBPreferredStockMember 2020-08-01 2020-08-31 0001409197 2020-11-01 2020-11-30 0001409197 2021-01-01 2021-01-21 0001409197 2021-02-03 2021-02-24 0001409197 bspk:DanilPollackMember us-gaap:StockOptionMember 2020-04-09 2020-04-21 0001409197 us-gaap:WarrantMember 2020-08-31 0001409197 us-gaap:WarrantMember 2020-09-01 2021-05-31 0001409197 us-gaap:WarrantMember 2021-05-31 0001409197 us-gaap:StockOptionMember 2020-08-31 0001409197 us-gaap:StockOptionMember 2021-05-31 0001409197 us-gaap:StockOptionMember 2020-09-01 2021-05-31 0001409197 2020-09-01 2020-09-30 0001409197 2021-04-01 2021-04-30 0001409197 bspk:EmploymentAgreementMember 2020-08-10 2020-08-31 0001409197 srt:ChiefExecutiveOfficerMember 2020-08-10 2020-08-31 0001409197 2020-11-10 0001409197 2020-06-01 2020-11-30 0001409197 2021-01-02 2021-01-06 0001409197 bspk:SecuritiesPurchaseAgreementMember 2018-05-06 2018-06-06 0001409197 2020-11-30 0001409197 bspk:SecuritiesPurchaseAgreementMember 2020-08-31 0001409197 bspk:SecuritiesPurchaseAgreementMember 2018-09-01 2019-08-31 0001409197 2021-01-05 0001409197 bspk:SecuritiesPurchaseAgreementMember 2020-09-30 2020-09-30 0001409197 2021-04-01 2021-04-01 0001409197 bspk:ConsultingAgreementMember 2020-10-01 2020-10-13 0001409197 srt:MinimumMember 2020-06-01 2020-08-31 0001409197 srt:MinimumMember bspk:MrRozenMember 2020-08-31 0001409197 srt:MaximumMember 2020-09-01 2021-05-31 0001409197 srt:MaximumMember 2021-05-31 0001409197 srt:MinimumMember us-gaap:SubsequentEventMember 2021-09-01 2021-11-30 0001409197 srt:MinimumMember bspk:MrRozenMember us-gaap:SubsequentEventMember 2021-11-30 0001409197 srt:MaximumMember us-gaap:SubsequentEventMember 2021-09-01 2021-11-30 0001409197 srt:MaximumMember bspk:MrRozenMember us-gaap:SubsequentEventMember 2021-11-30 0001409197 bspk:MrRozenMember us-gaap:SubsequentEventMember 2021-09-01 2021-11-30 0001409197 srt:MinimumMember 2020-12-01 2021-02-28 0001409197 srt:MinimumMember bspk:MrRozenMember 2021-02-28 0001409197 srt:MaximumMember 2020-12-01 2021-02-28 0001409197 srt:MaximumMember bspk:MrRozenMember 2021-02-28 0001409197 srt:MinimumMember 2021-03-01 2021-05-31 0001409197 srt:MinimumMember bspk:MrRozenMember 2021-05-31 0001409197 srt:MaximumMember 2021-03-01 2021-05-31 0001409197 srt:MaximumMember bspk:MrRozenMember 2021-05-31 0001409197 us-gaap:AccountsReceivableMember 2021-05-01 2021-05-31 0001409197 us-gaap:AccountsReceivableMember 2020-08-01 2020-08-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure false --08-31 Q3 2021 2021-05-31 10-Q 0001409197 Yes true false 000-52759 Non-accelerated Filer NV Yes BESPOKE EXTRACTS, INC. false true 246889621 83145 126603 4852 3585 92000 2319 76857 256854 132507 2745 33558 33741 13305 10872 293157 166248 62136 59913 534 120000 500000 500000 562670 679913 0.001 0.001 50000000 50000000 1 1 1 1 0.001 0.001 1000 1000 0.001 0.001 1 1 1 1 1 1 246889 194389 0.001 0.001 3000000000 3000000000 246888426 194388426 246888426 194388426 19066135 17992635 76000 -19582537 -18776689 -269513 -513665 293157 166248 10117 21684 1739 3186 7202 1087 6931 14482 652 206087 3161806 551170 3594236 22604 25367 85227 174153 77000 24562 181500 158062 811 811 2433 2797 306502 3212546 820330 3929248 -299571 -3212546 -805848 -3928596 -89595 242188 535688 -242188 -625283 -299571 -3454734 -805848 -4553879 -299571 -3454734 -805848 -4553879 246888426 111910165 225296851 105433560 0.00 -0.03 0.00 -0.04 1 1 110388426 110389 14796446 76000 -15235028 -252192 3150855 3150855 20000000 20000 20000 -1 -1 1 1 45333 45333 -3454734 -3454734 1 130388426 130389 17992635 76000 -18689762 -490738 1 246888426 246889 19066135 -19282966 30058 -299571 -299571 1 246888426 246889 19066135 -19582537 78155093 78156 13950095 76000 -14135883 -31632 1 1 23999 24000 20833333 20833 104167 125000 4500000 4500 36000 40500 3467440 3467440 20000000 20000 20000 9900000 9900 108800 118700 -3000000 3000 24500 27500 -1 -1 1 1 45333 45333 281300 281300 -4553879 -4553879 1 194388426 194389 17992635 76000 -18776689 20000000 20000 230000 250000 500000 500 75500 -76000 32000000 32000 768000 800000 -805848 -805848 2433 2797 535687 2981 -3467440 40500 1267 165 76857 -1907 89681 -6137 2223 -542 -968997 -407542 2250 2745 -4995 130534 400000 20000 120000 27500 800000 125000 930534 397500 -43458 -10042 10343 301 281300 118700 250000 45333 76000 5282 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>1. NATURE OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Nature of Business Operations</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Bespoke Extracts, Inc. (the &#x201c;Company&#x201d;) is a Nevada corporation focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company introduced its original line of CBD products in 2018. In the fall of 2020, the Company unveiled a new brand image, new website and ecommerce store and a new line-up of hemp-derived CBD formulations available for purchase in the form of tinctures, softgels and creams.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Basis of Presentation</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The accompanying condensed unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments consisting of a normal and recurring nature considered necessary for a fair presentation have been included. Operating results for the three and nine months ended May 31, 2021 may not necessarily be indicative of the results that may be expected for the year ended August 31, 2021.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">For further information, refer to the Company&#x2019;s financial statements and footnotes thereto included in the Annual Report on Form 10-K for the year ended August 31, 2020.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Certain prior period amounts have been reclassified to conform to the current period presentation.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Going Concern</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The accompanying condensed financial statements have been prepared assuming a continuation of the Company as a going concern. The Company had negative cash flows from operations, a working capital deficit and an accumulated deficit as of and for the nine months ended May 31, 2021.&#xa0;This raises substantial doubt about our ability to continue as a going concern.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company&#x2019;s ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repaying its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we will have to curtail or cease our operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. These financial statements do not include any adjustments that might arise from this uncertainty.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif">&#xa0;<b>Use of Estimates</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements and accompanying notes. Significant estimates include the assumption used in the valuation of equity-based transactions, valuation of intangible assets, allowance for doubtful accounts and inventory valuation and reserves. Actual results could differ from those estimates.&#xa0;</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Cash and Cash Equivalents</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents include all highly liquid investments with original maturities of three months or less at the time of purchase. At May 31, 2021 and August 31, 2020, the Company did not have any cash equivalents.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Fair Value of Financial Instruments</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The carrying amounts of cash, accounts receivable, prepaid expenses, inventory and other assets, accounts payable, accrued liabilities, note payable and convertible note payable approximate their fair values as of May 31, 2021 and August 31, 2020, respectively, because of their short-term natures and the Company&#x2019;s borrowing rate of interest.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Accounts Receivable</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company&#x2019;s customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased bad debt expense.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30 or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging off uncollectible receivables is made. At May 31, 2021 and August 31, 2020, the Company has recorded an allowance for doubtful accounts of $2,981 and $2,981, respectively. At May 31, 2021 and August 31, 2020 included in the accounts receivable is the merchant holdback receivable balance of $3,636 and $3,585, respectively which will be remitted to the Company in the future.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Inventory</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Inventories are stated at the lower of cost or net realizable value.&#xa0;Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of May 31, 2021 and August 31, 2020, inventory amounted to $76,857 and $0, respectively, which consisted of finished goods of $72,435, and raw materials of $4,422 net of reserves. During the nine months ended May 31, 2021 the Company adjusted the reserves by $6,776 for products sold. As of May 31, 2021 and August 31, 2020 inventory reserves were $33,476 and $40,252, respectively.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Revenue Recognition</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">We account for revenue in accordance with the <font>Financial Accounting Standards Board (&#x201c;FASB&#x201d;)&#xa0;</font>Accounting Standard Codification Topic&#xa0;606, &#x201c;Revenue from Contracts with Customers&#x201d;. Revenue is measured based on the amount of consideration that we expect to receive, reduced by discounts and estimates for credits and returns (calculated based upon previous experience and management&#x2019;s evaluation). Outbound shipping charged to customers is recognized at the time the related merchandise revenues are recognized and are included in net revenues. Inbound and outbound shipping and delivery costs are included in cost of revenues.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Our products are sold through our online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due on the date of shipment. The Company offers a 30 day return policy on sales.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Stock Option Plans</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Stock options and warrants issued to consultants and other non-employees as compensation for services provided to the Company are accounted for based on the fair value of the services provided or the estimated fair market value of the option or warrant, whichever is more reliably measurable, and in accordance FASB ASC 718<i>, Compensation-Stock Compensation,</i> including related amendments and interpretations. The related expense is recognized over the period the services are provided. Stock option compensation expense has been recognized as a component of general and administrative expenses in the accompanying financial statements for the three and nine months ended May 31, 2020. No stock option compensation expense was recognized for the three and nine months ended May 31, 2021.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Net Income / (Loss) per Share</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Basic income / (loss) per share amounts are computed based on net income / (loss) divided by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if potentially dilutive securities were exercised or converted to common stock. The dilutive effect of options and warrants and their equivalent is computed by application of the treasury stock method and the effect of convertible securities by the &#x201c;if converted&#x201d; method. The effect of 3,000,000 warrants and 0 options as well as 500,000,000 shares issuable upon the conversion of a convertible note are anti-dilutive for the three and nine months ended May 31, 2021. The effect of 3,450,000 warrants and 81,200,000 options is anti-dilutive for the three and nine months end May 31, 2020.&#xa0;&#xa0;</font></p><br/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Nature of Business Operations</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Bespoke Extracts, Inc. (the &#x201c;Company&#x201d;) is a Nevada corporation focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company introduced its original line of CBD products in 2018. In the fall of 2020, the Company unveiled a new brand image, new website and ecommerce store and a new line-up of hemp-derived CBD formulations available for purchase in the form of tinctures, softgels and creams.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Basis of Presentation</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The accompanying condensed unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments consisting of a normal and recurring nature considered necessary for a fair presentation have been included. Operating results for the three and nine months ended May 31, 2021 may not necessarily be indicative of the results that may be expected for the year ended August 31, 2021.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">For further information, refer to the Company&#x2019;s financial statements and footnotes thereto included in the Annual Report on Form 10-K for the year ended August 31, 2020.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Certain prior period amounts have been reclassified to conform to the current period presentation.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Going Concern</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The accompanying condensed financial statements have been prepared assuming a continuation of the Company as a going concern. The Company had negative cash flows from operations, a working capital deficit and an accumulated deficit as of and for the nine months ended May 31, 2021.&#xa0;This raises substantial doubt about our ability to continue as a going concern.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company&#x2019;s ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repaying its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we will have to curtail or cease our operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. These financial statements do not include any adjustments that might arise from this uncertainty.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Use of Estimates</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements and accompanying notes. Significant estimates include the assumption used in the valuation of equity-based transactions, valuation of intangible assets, allowance for doubtful accounts and inventory valuation and reserves. Actual results could differ from those estimates.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Cash and Cash Equivalents</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents include all highly liquid investments with original maturities of three months or less at the time of purchase. At May 31, 2021 and August 31, 2020, the Company did not have any cash equivalents.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Fair Value of Financial Instruments</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The carrying amounts of cash, accounts receivable, prepaid expenses, inventory and other assets, accounts payable, accrued liabilities, note payable and convertible note payable approximate their fair values as of May 31, 2021 and August 31, 2020, respectively, because of their short-term natures and the Company&#x2019;s borrowing rate of interest.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Accounts Receivable</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company&#x2019;s customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased bad debt expense.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30 or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging off uncollectible receivables is made. At May 31, 2021 and August 31, 2020, the Company has recorded an allowance for doubtful accounts of $2,981 and $2,981, respectively. At May 31, 2021 and August 31, 2020 included in the accounts receivable is the merchant holdback receivable balance of $3,636 and $3,585, respectively which will be remitted to the Company in the future.</font></p> 2981 2981 3636 3585 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Inventory</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Inventories are stated at the lower of cost or net realizable value.&#xa0;Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of May 31, 2021 and August 31, 2020, inventory amounted to $76,857 and $0, respectively, which consisted of finished goods of $72,435, and raw materials of $4,422 net of reserves. During the nine months ended May 31, 2021 the Company adjusted the reserves by $6,776 for products sold. As of May 31, 2021 and August 31, 2020 inventory reserves were $33,476 and $40,252, respectively.</font></p> 0 72435 4422 6776 33476 40252 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Revenue Recognition</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">We account for revenue in accordance with the <font>Financial Accounting Standards Board (&#x201c;FASB&#x201d;)&#xa0;</font>Accounting Standard Codification Topic&#xa0;606, &#x201c;Revenue from Contracts with Customers&#x201d;. Revenue is measured based on the amount of consideration that we expect to receive, reduced by discounts and estimates for credits and returns (calculated based upon previous experience and management&#x2019;s evaluation). Outbound shipping charged to customers is recognized at the time the related merchandise revenues are recognized and are included in net revenues. Inbound and outbound shipping and delivery costs are included in cost of revenues.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Our products are sold through our online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due on the date of shipment. The Company offers a 30 day return policy on sales.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Stock Option Plans</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Stock options and warrants issued to consultants and other non-employees as compensation for services provided to the Company are accounted for based on the fair value of the services provided or the estimated fair market value of the option or warrant, whichever is more reliably measurable, and in accordance FASB ASC 718<i>, Compensation-Stock Compensation,</i> including related amendments and interpretations. The related expense is recognized over the period the services are provided. Stock option compensation expense has been recognized as a component of general and administrative expenses in the accompanying financial statements for the three and nine months ended May 31, 2020. No stock option compensation expense was recognized for the three and nine months ended May 31, 2021.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Net Income / (Loss) per Share</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Basic income / (loss) per share amounts are computed based on net income / (loss) divided by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if potentially dilutive securities were exercised or converted to common stock. The dilutive effect of options and warrants and their equivalent is computed by application of the treasury stock method and the effect of convertible securities by the &#x201c;if converted&#x201d; method. The effect of 3,000,000 warrants and 0 options as well as 500,000,000 shares issuable upon the conversion of a convertible note are anti-dilutive for the three and nine months ended May 31, 2021. The effect of 3,450,000 warrants and 81,200,000 options is anti-dilutive for the three and nine months end May 31, 2020.</font></p> 3000000 0 500000000 3450000 81200000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>2. ASSET PURCHASE AGREEMENT</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On February 21, 2017, the Company purchased all right, title, interest and goodwill in or associated with certain domain names set forth in an asset purchase agreement for a total of $20,185 in cash and 200,000 shares of the Company&#x2019;s common stock valued at $30,000. During the year ended August 31, 2020, the Company transferred certain URLs valued at $5,282 to an unrelated party and impaired $289 leaving a balance of $44,614 of URL&#x2019;s. The domain names are being amortized over a 15 year period. During the three and nine months ended May 31, 2021, the Company recorded an amortization expense of $811 and $2,433, respectively. During the nine months ended May 31, 2020, the Company recorded an impairment expense of $289 for the expired domain names. During the three and nine months ended May 31, 2020, the Company recorded an amortization expense of $811 and $2,508 respectively.</font></p><br/> 20185 200000 30000 5282 289 44614 P15Y 811 2433 289 811 2508 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>3. NOTE PAYABLE - RELATED PARTY</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On August 31, 2020, the Company issued a promissory note in the principal amount of $150,000, to Danil Pollack, the Company&#x2019;s chief executive officer. $120,000 was remitted upon execution of the note and the remaining $30,000 was remitted on September 22, 2020. The note did not bear interest. On November 10, 2020, the Company entered into an exchange agreement with Mr. Pollack. Pursuant to the exchange agreement, Mr. Pollack exchanged the note for 15,000,000 shares of common stock of the Company.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During the nine months ended May 31, 2021, Mr. Pollack loaned the Company an additional $100,534 that was non-interest bearing and payable upon demand. $100,000 of this amount was subsequently deemed to be consideration for 5,000,000 shares of common stock the Company issued to Mr. Pollack on January 6, 2021.</font></p><br/> 150000 the Company&#x2019;s chief executive officer. $120,000 was remitted upon execution of the note and the remaining $30,000 was remitted on September 22, 2020. The note did not bear interest. On November 10, 2020, the Company entered into an exchange agreement with Mr. Pollack. Pursuant to the exchange agreement, Mr. Pollack exchanged the note for 15,000,000 shares of common stock of the Company. 100534 100000 5000000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>4. CONVERTIBLE NOTE PAYABLE</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 24, 2019, the Company entered into and closed a securities purchase agreement with an accredited investor, pursuant to which the Company issued and sold to the investor an original issue discount convertible debenture in the principal amount of $500,000, for a purchase price of $300,000. The Company also issued to the investor 5,000,000 shares of common stock valued at $55,000 ($0.005 per share). The Company recorded beneficial conversion of $245,000 due to the conversion feature. The debenture may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company&#x2019;s outstanding common stock. The debenture had an original maturity date of April 30, 2020 and was convertible into shares of common stock of the Company at an initial conversion price of $0.001, except that, if the Company failed to repay the debenture upon maturity, the conversion price would be reduced to $0.0004 (subject to adjustment for stock splits, stock dividends, and similar transactions) and the debenture would bear interest at the rate of 9% per year. The Company&#x2019;s obligation to repay the debenture upon maturity was initially secured by a security interest in the Company&#x2019;s inventory pursuant to a security agreement between the Company and the investor. For the year ended August 31, 2020 the Company recorded amortization of debt discount of $500,000. A portion of the debenture was subsequently sold by the original purchaser to a third party. On April 23, 2020, the Company entered into an amendment to the security agreement with the holders of the debentures. Pursuant to the security agreement amendment, the collateral under the security agreement was amended to be the Company&#x2019;s URLs. The Company has also entered into five amendments to the debentures to extend the maturity date, including, most recently, an amendment entered into on August 2, 2021, to extend the maturity date to August 31, 2021.</p><br/> 500000 300000 5000000 55000 0.005 245000 2020-04-30 0.001 0.0004 0.09 500000 more than 4.99% <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>5. EQUITY</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Common Stock and Preferred Stock</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As of August 31, 2020, the Company had authorized capital of 800,000,000 shares of common stock with a par value of $0.001, and 50,000,000 shares of preferred stock with a par value of $0.001. On October 2, 2020, the Company filed a certificate of amendment to the Company&#x2019;s articles of incorporation with the Secretary of State of Nevada, pursuant to which the Company increased its authorized shares of common stock from 800,000,000 to 3,000,000,000. 1,000 shares of preferred stock are designated as Series A Convertible Preferred Stock. No shares of Series A Preferred Stock are issued and outstanding as of August 31, 2020 and May 31, 2021 respectively. The Company&#x2019;s Certificate of Designation of Series B Preferred Stock was withdrawn by the Company on June 30, 2020. 1 share of preferred stock is designated Series C Preferred Stock and is issued and outstanding as of August 31, 2020 and May 31, 2021, respectively. The Series C Preferred Stock has a stated value of $24,000 and entitles the holder to 51% of the total voting power of the Company&#x2019;s stockholders. The Company may, in its sole discretion, redeem the Series C Preferred Stock at any time for a redemption price equal to the stated value. Upon payment of the redemption price by the Company, the Series C Preferred Stock will revert to the status of authorized but unissued preferred stock.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Pursuant to a securities purchase agreement entered into on June 6, 2018 the Company was obligated to issue additional shares of common stock if the Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser would be equal to $50,000 divided by lower financing price. As of August 31, 2020, the Company was obligated to issue 500,000 shares of common stock valued at $76,000. On January 5, 2021, the Company issued the 500,000 shares of common stock.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On August 31, 2020, the Company issued a promissory note in the principal amount of $150,000, to Danil Pollack, the Company&#x2019;s chief executive officer. $120,000 was remitted upon execution of the note and the remaining $30,000 was remitted on September 22, 2020. The note did not bear interest. On November 10, 2020, the Company entered into an exchange agreement with Mr. Pollack. Pursuant to the exchange agreement, Mr. Pollack exchanged the promissory note for 15,000,000 shares of common stock of the Company.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During the nine months ended May 31, 2021, Mr. Pollack loaned the Company an additional $100,534 that was non-interest bearing and payable upon demand. $100,000 of this amount was subsequently deemed to be consideration for 5,000,000 shares of common stock the Company issued to Mr. Pollack on January 6, 2021.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On November 30, 2020, the Company entered into a securities purchase agreement with Danil Pollack. Pursuant to the purchase agreement, the Company issued and sold to Mr. Pollack 20,000,000 shares of common stock for an aggregate purchase price of $200,000.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On January 21, 2021, the Company entered into a securities purchase agreement with Danil Pollack. Pursuant to the purchase agreement, the Company issued and sold to Mr. Pollack 2,000,000 shares of common stock for an aggregate purchase price of $100,000.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On February 24, 2021, the Company entered into a securities purchase agreement with an accredited investor. Pursuant to the purchase agreement, the Company issued and sold to the investor 10,000,000 shares of common stock for an aggregate purchase price of $500,000.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Warrants&#xa0;</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The following table summarizes the warrant activities during the nine months ended May 31, 2021:</font></p><br/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of<br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average<br/> Price Per<br/> Share</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average<br/> Remaining <br/> Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 65%">Outstanding at August 31, 2020</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 9%; text-align: right">3,450,000</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.56</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 9%; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2.8 years</font></td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td>Granted</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Canceled or expired</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">(450,000</td><td style="text-align: left">)</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">0.81</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Exercised</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Outstanding at May 31, 2021</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#xa0;</td><td style="border-bottom: Black 4pt double; text-align: right">3,000,000</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.52</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2.41 years</font></td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Exercisable at May 31, 2021</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt; text-align: right">3,000,000</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.52</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2.41 years</font></td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Intrinsic value at May 31, 2021</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt; text-align: right">&#xa0;</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; text-align: center">&#xa0;</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Options</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On April 21, 2020, Danil Pollack was appointed president, chief executive officer, and chief financial officer of the Company. In connection with Mr. Pollack&#x2019;s appointment, the Company entered into an employment agreement with Mr. Pollack. Pursuant to the employment agreement, Mr. Pollack will serve as the Company&#x2019;s chief executive officer and president for a period of one year, which term will renew automatically for successive one year terms, subject to the right of either party to terminate the agreement at any time upon written notice. Mr. Pollack was granted the right, for a period of six months, to purchase up to 100,000,000 shares of common stock of the Company for a purchase price of $0.001 per share. The Company recognized option expense of $1,416,975 during the year ended August 31, 2020. During the year ended August 31, 2020, Mr. Pollack exercised 84,000,000 stock options for $84,000. During the nine months ended May 31, 2021, the remaining 16,000,000 stock options expired.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The following table summarizes the option activities during the nine months ended May 31, 2021:</font></p><br/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of <br/> Options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average <br/> Price Per <br/> Share</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average<br/> Remaining <br/> Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 65%">Outstanding at August 31, 2020</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 9%; text-align: right">16,000,000</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">.001</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 9%; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">0.9 years</font></td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td>Granted</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Canceled or expired</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">(16,000,000</td><td style="text-align: left">)</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">.001</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Exercised</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: right">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Outstanding at May 31, 2021</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#xa0;</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; text-align: right">&#xa0;</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Exercisable at May 31, 2021</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#xa0;</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; text-align: right">&#xa0;</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table><br/> 800000000 On October 2, 2020, the Company filed a certificate of amendment to the Company&#x2019;s articles of incorporation with the Secretary of State of Nevada, pursuant to which the Company increased its authorized shares of common stock from 800,000,000 to 3,000,000,000. 1,000 shares of preferred stock are designated as Series A Convertible Preferred Stock. The Series C Preferred Stock has a stated value of $24,000 and entitles the holder to 51% of the total voting power of the Company&#x2019;s stockholders. on June 6, 2018 the Company was obligated to issue additional shares of common stock if the Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser would be equal to $50,000 divided by lower financing price. As of August 31, 2020, the Company was obligated to issue 500,000 shares of common stock valued at $76,000. On January 5, 2021, the Company issued the 500,000 shares of common stock. 150000 120000 upon execution of the note and the remaining $30,000 was remitted on September 22, 2020. The note did not bear interest. On November 10, 2020, the Company entered into an exchange agreement with Mr. Pollack. Pursuant to the exchange agreement, Mr. Pollack exchanged the promissory note for 15,000,000 shares of common stock of the Company. 100534 100000 5000000 20000000 200000 2000000 100000 10000000 500000 Pursuant to the employment agreement, Mr. Pollack will serve as the Company&#x2019;s chief executive officer and president for a period of one year, which term will renew automatically for successive one year terms, subject to the right of either party to terminate the agreement at any time upon written notice. Mr. Pollack was granted the right, for a period of six months, to purchase up to 100,000,000 shares of common stock of the Company for a purchase price of $0.001 per share. The Company recognized option expense of $1,416,975 during the year ended August 31, 2020. During the year ended August 31, 2020, Mr. Pollack exercised 84,000,000 stock options for $84,000. During the nine months ended May 31, 2021, the remaining 16,000,000 stock options expired. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of<br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average<br/> Price Per<br/> Share</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average<br/> Remaining <br/> Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 65%">Outstanding at August 31, 2020</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 9%; text-align: right">3,450,000</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.56</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 9%; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2.8 years</font></td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td>Granted</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Canceled or expired</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">(450,000</td><td style="text-align: left">)</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">0.81</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Exercised</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Outstanding at May 31, 2021</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#xa0;</td><td style="border-bottom: Black 4pt double; text-align: right">3,000,000</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.52</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2.41 years</font></td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Exercisable at May 31, 2021</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt; text-align: right">3,000,000</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.52</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2.41 years</font></td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Intrinsic value at May 31, 2021</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt; text-align: right">&#xa0;</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; text-align: center">&#xa0;</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table> 3450000 0.56 P2Y292D -450000 0.81 3000000 0.52 P2Y149D 3000000 0.52 P2Y149D <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of <br/> Options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average <br/> Price Per <br/> Share</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average<br/> Remaining <br/> Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 65%">Outstanding at August 31, 2020</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 9%; text-align: right">16,000,000</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">.001</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 9%; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">0.9 years</font></td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td>Granted</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Canceled or expired</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">(16,000,000</td><td style="text-align: left">)</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">.001</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Exercised</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: right">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Outstanding at May 31, 2021</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#xa0;</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; text-align: right">&#xa0;</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Exercisable at May 31, 2021</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#xa0;</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; text-align: right">&#xa0;</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table> 16000000 0.001 P328D 16000000 0.001 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>6. RELATED PARTY TRANSACTIONS</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On September 30, 2020, the Company entered into an amendment to the Company&#x2019;s employment agreement, dated April 22, 2020, with Danil Pollack, the Company&#x2019;s chief executive officer. Pursuant to the amendment, the Company will pay Mr. Pollack an annual salary of $48,000. The Company may also in its discretion pay additional compensation to Mr. Pollack at any time as a bonus. On April 27, 2021, the Company entered into an amendment to the Company&#x2019;s employment agreement with Mr. Pollack. Pursuant to the amendment, the Company will pay Mr. Pollack an annual salary of $66,000 effective April 1, 2021. The Company may also in its discretion pay additional compensation to Mr. Pollack at any time as a bonus.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On August 31, 2020, the Company issued a promissory note in the principal amount of $150,000, to Danil Pollack. $120,000 was remitted upon execution of the note and the remaining $30,000 was paid on September 22, 2020. The note did not bear interest. On November 10, 2020, the Company entered into an exchange agreement with Mr. Pollack. Pursuant to the exchange agreement, Mr. Pollack exchanged this note for 15,000,000 shares of common stock of the Company.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During the nine months ended May 31, 2021, Mr. Pollack loaned the Company an additional $100,534 that was non-interest bearing and payable upon demand. $100,000 of this amount was subsequently deemed to be consideration for 5,000,000 shares of common stock the Company issued to Mr. Pollack on January 6, 2021.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On November 30, 2020, the Company entered into a securities purchase agreement with Mr. Pollack. Pursuant to the purchase agreement, the Company issued and sold to Mr. Pollack 20,000,000 shares of common stock for an aggregate purchase price of $200,000.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On January 21, 2021, the Company entered into a securities purchase agreement with Danil Pollack. Pursuant to the purchase agreement, the Company issued and sold to Mr. Pollack 2,000,000 shares of common stock for an aggregate purchase price of $100,000.</font></p><br/> 48000 66000 the Company issued a promissory note in the principal amount of $150,000, to Danil Pollack. $120,000 was remitted upon execution of the note and the remaining $30,000 was paid on September 22, 2020. Pursuant to the exchange agreement, Mr. Pollack exchanged this note for 15,000,000 shares of common stock of the Company. 15000000 100534 100000 5000000 20000000 200000 2000000 100000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>7. COMMITMENTS AND CONTINGENCIES</b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Pursuant to a securities purchase agreement entered into on June 6, 2018 the Company was obligated to issue additional shares of common stock if the Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser would be equal to $50,000 divided by lower financing price. As of November 30, 2020 and August 31, 2020, the Company was obligated to issue 500,000 shares of common stock valued at $76,000 which is included in the common stock payable in the accompanying balance sheet. On January 5, 2021, the Company issued 500,000 shares of common stock.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On April 21, 2020, Danil Pollack was appointed president, chief executive officer, and chief financial officer of the Company. In connection with Mr. Pollack&#x2019;s appointment, the Company entered into an employment agreement with Mr. Pollack. On September 30, 2020, the Company entered into an amendment to the employment agreement. Pursuant to the amendment, the Company will pay Mr. Pollack an annual salary of $48,000. The Company may also in its discretion pay additional compensation to Mr. Pollack at any time as a bonus. On April 27, 2021, the Company entered into an amendment to the Company&#x2019;s employment agreement with Mr. Pollack. Pursuant to the amendment, the Company will pay Mr. Pollack an annual salary of $66,000 effective April 1, 2021. The Company may also in its discretion pay additional compensation to Mr. Pollack at any time as a bonus.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On October 13, 2020, the Company entered into a consulting agreement with Yaniv Rozen pursuant to which the Company engaged Mr. Rozen to serve as the Company&#x2019;s chief operating officer on a consultant/independent contractor basis. Mr. Rozen was permitted to engage in other business activities while serving as the Company&#x2019;s chief operating officer. On July 1, 2021, Yaniv Rozen resigned as chief operating officer of the Company.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Pursuant to the consulting agreement, the Company agreed to pay Mr. Rozen a fee of $3,000 per month.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company also agreed to issue to Mr. Rozen shares of common stock, and increase such monthly fee, as follows:</font></p><br/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><font style="font: 10pt Times New Roman, Times, Serif">&#xa0;</font></td> <td style="width: 24px"><font style="font: 10pt Times New Roman, Times, Serif">&#x25cf;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Within five business day of the end of the fourth quarter of 2020, (i) if the Company&#x2019;s average sales were at least $50,000 per month, for such quarter, the Company would issue to Mr. Rozen 500,000 shares of common stock; or (ii) if the Company&#x2019;s average sales were at least $100,000 per month for such quarter, the Company would issue to Mr. Rozen 750,000 shares of common stock;</font></td></tr> </table><br/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><font style="font: 10pt Times New Roman, Times, Serif">&#xa0;</font></td> <td style="width: 24px"><font style="font: 10pt Times New Roman, Times, Serif">&#x25cf;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Within five business day of the end of the first quarter of 2021, (i) if the Company&#x2019;s average sales were at least $100,000 per month for such quarter, the Company would issue to Mr. Rozen 750,000 shares of common stock, or (ii) if the Company&#x2019;s average sales were at least $150,000 per month for such quarter, the Company would issue to Mr. Rozen 1,000,000 shares of common stock, and would increase Mr. Rozen&#x2019;s fee to $5,000 per month effective commencing at the end such quarter;</font></td></tr> </table><br/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><font style="font: 10pt Times New Roman, Times, Serif">&#xa0;</font></td> <td style="width: 24px"><font style="font: 10pt Times New Roman, Times, Serif">&#x25cf;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Within five business days of the end of the second quarter of 2021, (i) if the Company&#x2019;s average sales were at least $200,000 per month, for such quarter, the Company would issue to Mr. Rozen 1,500,000 shares of common stock, or (ii) if the Company&#x2019;s average sales were at least $300,000 per month, for such quarter, the Company would issue to Mr. Rozen 2,000,000 shares of common stock; and</font></td></tr> </table><br/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><font style="font: 10pt Times New Roman, Times, Serif">&#xa0;</font></td> <td style="width: 24px"><font style="font: 10pt Times New Roman, Times, Serif">&#x25cf;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Within five business days of the end of the third quarter of 2021, (i) if the Company&#x2019;s average sales were at least $300,000 per month, for such quarter, the Company would issue to Mr. Rozen 2,000,000 shares of common stock; or (ii) if the Company&#x2019;s average sales were at least $500,000 per month, for such quarter, the Company would issue to Mr. Rozen 3,000,000 shares of common stock, and would increase Mr. Rozen&#x2019;s fee to $7,000 per month effective commencing at the end such quarter.</font></td></tr> </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of July 1, 2021, Mr. Rozen&#x2019;s resignation date, there was no common stock owed to Mr. Rozen as the quarterly target sales were not met.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The COVID-19 pandemic may negatively affect our operations, including by limiting access to our facilities, customers, management, and professional advisors, and causing delays and constraints in manufacturing and shipping of our products. These factors, in turn, may negatively impact our operations, financial condition and demand for our products, and our ability to raise capital on acceptable terms, or at all.</font></p><br/> 0.10 0.10 50000 500000 500000 76000 500000 48000 66000 3000 50000 500000 100000 750000 100000 750000 150000 1000000 5000 200000 1500000 300000 2000000 5 300000 2000000 500000 3000000 7000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>8. MAJOR CUSTOMERS </b></font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">At May 31, 2021 and August 31, 2020, no individual customer amounted to over 10% of total accounts receivable. During the three and nine months ended May 31, 2021 and May 31, 2020 no individual customer amounted to over 10% of total sales.&#xa0;</font></p><br/> 0 0.10 0 0 0.10 0.10 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>9. SUBSEQUENT EVENTS</b>&#xa0;</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On July 1, 2021, Yaniv Rozen resigned as chief operating officer of the Company. See Note 7.</font></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 2, 2021, the Company entered into amendments (&#x201c;Amendment No. 6&#x201d;) with the holders of the Company&#x2019;s original issue discount convertible debentures, with an original issuance date of December 24, 2019, as amended by amendment No. 1 thereto, dated May 28, 2020, amendment No. 2 thereto, dated August 21, 2020, amendment No. 3 thereto, dated December 10, 2020, Amendment No. 4 thereto, dated January 15, 2021, and Amendment No. 5 thereto, dated April 2, 2021, in the aggregate outstanding principal amount of $500,000. Pursuant to Amendment No. 6, the maturity date of the debentures was extended to August 31, 2021.</font></p><br/> 500000 EX-101.SCH 5 bspk-20210531.xsd XBRL SCHEMA FILE 001 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Statement of Stockholders Deficit link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Nature of Operations, Significant Accounting Policies and Going Concern link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Asset Purchase Agreement link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Note Payable - Related Party link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Convertible Note Payable link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Equity link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Major Customers link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Nature of Operations, Significant Accounting Policies and Going Concern (Details) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Asset Purchase Agreement (Details) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Note Payable - Related Party (Details) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Convertible Note Payable (Details) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Equity (Details) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Equity (Details) - Schedule of warrants link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Equity (Details) - Schedule of stock options link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Major Customers (Details) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 6 bspk-20210531_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 bspk-20210531_def.xml XBRL DEFINITION FILE EX-101.LAB 8 bspk-20210531_lab.xml XBRL LABEL FILE EX-101.PRE 9 bspk-20210531_pre.xml XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document And Entity Information - shares
9 Months Ended
May 31, 2021
Aug. 10, 2021
Document Information Line Items    
Entity Registrant Name BESPOKE EXTRACTS, INC.  
Document Type 10-Q  
Current Fiscal Year End Date --08-31  
Entity Common Stock, Shares Outstanding   246,889,621
Amendment Flag false  
Entity Central Index Key 0001409197  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date May 31, 2021  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q3  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company false  
Entity Ex Transition Period false  
Entity File Number 000-52759  
Entity Incorporation, State or Country Code NV  
Entity Interactive Data Current Yes  
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Balance Sheets - USD ($)
May 31, 2021
Aug. 31, 2020
Current assets    
Cash $ 83,145 $ 126,603
Accounts receivable, net 4,852 3,585
Prepaid expense 92,000 2,319
Inventory, net 76,857
Total current assets 256,854 132,507
Furniture and equipment 2,745
Domain names, net of amortization of $13,305 and $10,872, respectively 33,558 33,741
Total assets 293,157 166,248
Current liabilities    
Accounts payable and accrued liabilities 62,136 59,913
Note payable - related party 534 120,000
Convertible notes 500,000 500,000
Total current liabilities 562,670 679,913
Commitments and contingencies (Note 7)
Stockholders’ Deficit    
Preferred stock, value
Common stock, $0.001 par value: 3,000,000,000 shares authorized; 246,888,426 and 194,388,426 shares issued and outstanding as of May 31, 2021 and August 31, 2020, respectively 246,889 194,389
Additional paid-in capital 19,066,135 17,992,635
Common stock payable 76,000
Accumulated deficit (19,582,537) (18,776,689)
Total stockholders’ deficit (269,513) (513,665)
Total liabilities and stockholders’ deficit 293,157 166,248
Series A Convertible Preferred Stock    
Stockholders’ Deficit    
Preferred stock, value
Series C Preferred Stock    
Stockholders’ Deficit    
Preferred stock, value
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Balance Sheets (Parentheticals) - USD ($)
May 31, 2021
Aug. 31, 2020
Net of amortization cost (in Dollars) $ 13,305 $ 10,872
Preferred stock, par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized 50,000,000 50,000,000
Preferred stock, shares issued 1 1
Preferred stock, shares outstanding 1 1
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, authorized 3,000,000,000 3,000,000,000
Common stock, shares issued 246,888,426 194,388,426
Common stock, shares outstanding 246,888,426 194,388,426
Series A Convertible Preferred Stock    
Preferred stock, par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares issued
Preferred stock, shares outstanding
Preferred stock, designated shares 1,000 1,000
Series C Preferred Stock    
Preferred stock, par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares issued 1 1
Preferred stock, shares outstanding 1 1
Preferred stock, designated shares 1 1
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
May 31, 2021
May 31, 2020
May 31, 2021
May 31, 2020
Income Statement [Abstract]        
Sales $ 10,117 $ 21,684 $ 1,739
Cost of products sold 3,186 7,202 1,087
Gross Profit 6,931 14,482 652
Operating expenses:        
Selling, general and administrative expenses 206,087 3,161,806 551,170 3,594,236
Professional fees 22,604 25,367 85,227 174,153
Consulting 77,000 24,562 181,500 158,062
Amortization expense of domain name 811 811 2,433 2,797
Total operating expenses 306,502 3,212,546 820,330 3,929,248
Loss from operations (299,571) (3,212,546) (805,848) (3,928,596)
Other expense        
Loss on settlement of debt (89,595)
Interest expense and amortization of debt discount (242,188) (535,688)
Total other expense (242,188) (625,283)
Loss before income tax (299,571) (3,454,734) (805,848) (4,553,879)
Provision for income tax
Net Loss $ (299,571) $ (3,454,734) $ (805,848) $ (4,553,879)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING        
Basic and Diluted (in Shares) 246,888,426 111,910,165 225,296,851 105,433,560
LOSS PER COMMON SHARE OUTSTANDING        
Basic and Diluted (in Dollars per share) $ 0.00 $ (0.03) $ 0.00 $ (0.04)
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statement of Stockholders Deficit - USD ($)
Series A
Preferred Shares Outstanding
Series B
Preferred Shares Outstanding
Series C
Preferred Shares Outstanding
Common Shares Outstanding
Additional Paid in Capital
Common Stock Payable
Accumulated Deficit
Total
Balance at Aug. 31, 2019 $ 78,156 $ 13,950,095 $ 76,000 $ (14,135,883) $ (31,632)
Balance (in Shares) at Aug. 31, 2019     78,155,093        
Preferred stock issued for the conversion of accrued salary $ 1 23,999   24,000
Preferred stock issued for the conversion of accrued salary (in Shares)   1          
Sale of common stock $ 20,833 104,167   125,000
Sale of common stock (in Shares)       20,833,333        
Common stock issued for services $ 4,500 36,000   40,500
Common stock issued for services (in Shares)       4,500,000        
Options and warrant expense     3,467,440   3,467,440
Exercise of stock options $ 20,000   20,000
Exercise of stock options (in Shares)       20,000,000        
Common stock issued with debt $ 9,900 108,800   118,700
Common stock issued with debt (in Shares)       9,900,000        
Repurchase of common stock $ (3,000) (24,500)   (27,500)
Repurchase of common stock (in Shares)       (3,000,000)        
Exchange of preferred stock $ (1)   1
Exchange of preferred stock (in Shares) (1) 1          
Capital contribution of accrued salary - related party   45,333   45,333
Capital contribution of accrued salary - related party (in Shares)              
Beneficial conversion feature 281,300     281,300
Net loss             (4,553,879) (4,553,879)
Balance at May. 31, 2020 $ 130,389 17,992,635 76,000 (18,689,762) (490,738)
Balance (in Shares) at May. 31, 2020 1 130,388,426        
Balance at Feb. 29, 2020 $ 1 $ 110,389 14,796,446 76,000 (15,235,028) (252,192)
Balance (in Shares) at Feb. 29, 2020 1   110,388,426        
Options and warrant expense         3,150,855     3,150,855
Exercise of stock options $ 20,000       20,000
Exercise of stock options (in Shares)       20,000,000        
Exchange of preferred stock $ (1)   1
Exchange of preferred stock (in Shares)   (1) 1          
Capital contribution of accrued salary - related party   45,333 45,333
Net loss             (3,454,734) (3,454,734)
Balance at May. 31, 2020 $ 130,389 17,992,635 76,000 (18,689,762) (490,738)
Balance (in Shares) at May. 31, 2020 1 130,388,426        
Balance at Aug. 31, 2020   $ 194,389 17,992,635 76,000 (18,776,689) (513,665)
Balance (in Shares) at Aug. 31, 2020     1 194,388,426        
Sale of common stock       $ 32,000 768,000     800,000
Sale of common stock (in Shares)       32,000,000        
Common stock for conversion of note payable - related party       $ 20,000 230,000   250,000
Common stock for conversion of note payable - related party (in Shares)       20,000,000        
Exchange of common stock payable       $ 500 75,500 (76,000)  
Exchange of common stock payable (in Shares)       500,000        
Net loss             (805,848) (805,848)
Balance at May. 31, 2021   $ 246,889 19,066,135 (19,582,537) (269,513)
Balance (in Shares) at May. 31, 2021     1 246,888,426        
Balance at Feb. 28, 2021   $ 246,889 19,066,135 (19,282,966) 30,058
Balance (in Shares) at Feb. 28, 2021     1 246,888,426        
Net loss             (299,571) (299,571)
Balance at May. 31, 2021   $ 246,889 $ 19,066,135 $ (19,582,537) $ (269,513)
Balance (in Shares) at May. 31, 2021     1 246,888,426        
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
May 31, 2021
May 31, 2020
Cash flows from operating activities    
Net Loss $ (805,848) $ (4,553,879)
Adjustments to reconcile net loss to net cash used in operating activities    
Amortization and impairment expense of domain names 2,433 2,797
Amortization of debt discounts   535,687
Bad debt expense   2,981
Loss on settlement of debt 89,595
Option and warrant expense   3,467,440
Common stock issued for services   40,500
Changes in operating assets and liabilities:    
Accounts receivable (1,267) (165)
Inventory (76,857) 1,907
Prepaid expense (89,681) 6,137
Accounts payable and accrued liabilities 2,223 (542)
Net Cash used in operating activities (968,997) (407,542)
Cash flows from investing activities    
Purchase of Url (2,250)  
Purchase of equipment (2,745)  
Net cash used in investing activities (4,995)  
Cash flow from financing activities    
Proceeds from note payable - related party 130,534  
Proceeds from the issuance of convertible debt   400,000
Proceeds from exercise of stock options for cash   20,000
Repayment of debt   (120,000)
Repurchase of common stock   (27,500)
Sale of common stock 800,000 125,000
Net cash provided by financing activities 930,534 397,500
Net decrease in cash (43,458) (10,042)
Cash at beginning of period 126,603 10,343
Cash at end of period 83,145 301
Supplemental disclosure of cash flow information    
Cash paid for interest
Cash paid for income taxes
Noncash investing and financing activities:    
Discount due beneficial conversion feature   281,300
Stock issued with convertible debt   118,700
Stock issued for conversion of debt - related party 250,000  
Capital contribution of salary - related party   45,333
Stock issued for common stock payable $ 76,000  
Preferred stock issued for the conversion of accrued salary   24,000
Assignment of URL for settlement of debt   $ 5,282
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Nature of Operations, Significant Accounting Policies and Going Concern
9 Months Ended
May 31, 2021
Accounting Policies [Abstract]  
NATURE OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN

1. NATURE OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN


Nature of Business Operations


Bespoke Extracts, Inc. (the “Company”) is a Nevada corporation focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products.


The Company introduced its original line of CBD products in 2018. In the fall of 2020, the Company unveiled a new brand image, new website and ecommerce store and a new line-up of hemp-derived CBD formulations available for purchase in the form of tinctures, softgels and creams.


Basis of Presentation


The accompanying condensed unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments consisting of a normal and recurring nature considered necessary for a fair presentation have been included. Operating results for the three and nine months ended May 31, 2021 may not necessarily be indicative of the results that may be expected for the year ended August 31, 2021.


For further information, refer to the Company’s financial statements and footnotes thereto included in the Annual Report on Form 10-K for the year ended August 31, 2020.


Certain prior period amounts have been reclassified to conform to the current period presentation.


Going Concern


The accompanying condensed financial statements have been prepared assuming a continuation of the Company as a going concern. The Company had negative cash flows from operations, a working capital deficit and an accumulated deficit as of and for the nine months ended May 31, 2021. This raises substantial doubt about our ability to continue as a going concern.


The Company’s ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repaying its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed.


Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we will have to curtail or cease our operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. These financial statements do not include any adjustments that might arise from this uncertainty.


 Use of Estimates


The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements and accompanying notes. Significant estimates include the assumption used in the valuation of equity-based transactions, valuation of intangible assets, allowance for doubtful accounts and inventory valuation and reserves. Actual results could differ from those estimates. 


Cash and Cash Equivalents


Cash and cash equivalents include all highly liquid investments with original maturities of three months or less at the time of purchase. At May 31, 2021 and August 31, 2020, the Company did not have any cash equivalents.


Fair Value of Financial Instruments


The carrying amounts of cash, accounts receivable, prepaid expenses, inventory and other assets, accounts payable, accrued liabilities, note payable and convertible note payable approximate their fair values as of May 31, 2021 and August 31, 2020, respectively, because of their short-term natures and the Company’s borrowing rate of interest.


Accounts Receivable


Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased bad debt expense.


The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30 or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging off uncollectible receivables is made. At May 31, 2021 and August 31, 2020, the Company has recorded an allowance for doubtful accounts of $2,981 and $2,981, respectively. At May 31, 2021 and August 31, 2020 included in the accounts receivable is the merchant holdback receivable balance of $3,636 and $3,585, respectively which will be remitted to the Company in the future.


Inventory


Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of May 31, 2021 and August 31, 2020, inventory amounted to $76,857 and $0, respectively, which consisted of finished goods of $72,435, and raw materials of $4,422 net of reserves. During the nine months ended May 31, 2021 the Company adjusted the reserves by $6,776 for products sold. As of May 31, 2021 and August 31, 2020 inventory reserves were $33,476 and $40,252, respectively.


Revenue Recognition


We account for revenue in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification Topic 606, “Revenue from Contracts with Customers”. Revenue is measured based on the amount of consideration that we expect to receive, reduced by discounts and estimates for credits and returns (calculated based upon previous experience and management’s evaluation). Outbound shipping charged to customers is recognized at the time the related merchandise revenues are recognized and are included in net revenues. Inbound and outbound shipping and delivery costs are included in cost of revenues.


Our products are sold through our online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due on the date of shipment. The Company offers a 30 day return policy on sales.


Stock Option Plans


Stock options and warrants issued to consultants and other non-employees as compensation for services provided to the Company are accounted for based on the fair value of the services provided or the estimated fair market value of the option or warrant, whichever is more reliably measurable, and in accordance FASB ASC 718, Compensation-Stock Compensation, including related amendments and interpretations. The related expense is recognized over the period the services are provided. Stock option compensation expense has been recognized as a component of general and administrative expenses in the accompanying financial statements for the three and nine months ended May 31, 2020. No stock option compensation expense was recognized for the three and nine months ended May 31, 2021.


Net Income / (Loss) per Share


Basic income / (loss) per share amounts are computed based on net income / (loss) divided by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if potentially dilutive securities were exercised or converted to common stock. The dilutive effect of options and warrants and their equivalent is computed by application of the treasury stock method and the effect of convertible securities by the “if converted” method. The effect of 3,000,000 warrants and 0 options as well as 500,000,000 shares issuable upon the conversion of a convertible note are anti-dilutive for the three and nine months ended May 31, 2021. The effect of 3,450,000 warrants and 81,200,000 options is anti-dilutive for the three and nine months end May 31, 2020.  


XML 17 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Asset Purchase Agreement
9 Months Ended
May 31, 2021
Asset Purchase Agreement [Abstract]  
ASSET PURCHASE AGREEMENT

2. ASSET PURCHASE AGREEMENT


On February 21, 2017, the Company purchased all right, title, interest and goodwill in or associated with certain domain names set forth in an asset purchase agreement for a total of $20,185 in cash and 200,000 shares of the Company’s common stock valued at $30,000. During the year ended August 31, 2020, the Company transferred certain URLs valued at $5,282 to an unrelated party and impaired $289 leaving a balance of $44,614 of URL’s. The domain names are being amortized over a 15 year period. During the three and nine months ended May 31, 2021, the Company recorded an amortization expense of $811 and $2,433, respectively. During the nine months ended May 31, 2020, the Company recorded an impairment expense of $289 for the expired domain names. During the three and nine months ended May 31, 2020, the Company recorded an amortization expense of $811 and $2,508 respectively.


XML 18 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Note Payable - Related Party
9 Months Ended
May 31, 2021
Debt Disclosure [Abstract]  
NOTE PAYABLE - RELATED PARTY

3. NOTE PAYABLE - RELATED PARTY


On August 31, 2020, the Company issued a promissory note in the principal amount of $150,000, to Danil Pollack, the Company’s chief executive officer. $120,000 was remitted upon execution of the note and the remaining $30,000 was remitted on September 22, 2020. The note did not bear interest. On November 10, 2020, the Company entered into an exchange agreement with Mr. Pollack. Pursuant to the exchange agreement, Mr. Pollack exchanged the note for 15,000,000 shares of common stock of the Company.


During the nine months ended May 31, 2021, Mr. Pollack loaned the Company an additional $100,534 that was non-interest bearing and payable upon demand. $100,000 of this amount was subsequently deemed to be consideration for 5,000,000 shares of common stock the Company issued to Mr. Pollack on January 6, 2021.


XML 19 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Convertible Note Payable
9 Months Ended
May 31, 2021
Convertible Debenture Related Party [Abstract]  
CONVERTIBLE NOTE PAYABLE

4. CONVERTIBLE NOTE PAYABLE


On December 24, 2019, the Company entered into and closed a securities purchase agreement with an accredited investor, pursuant to which the Company issued and sold to the investor an original issue discount convertible debenture in the principal amount of $500,000, for a purchase price of $300,000. The Company also issued to the investor 5,000,000 shares of common stock valued at $55,000 ($0.005 per share). The Company recorded beneficial conversion of $245,000 due to the conversion feature. The debenture may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock. The debenture had an original maturity date of April 30, 2020 and was convertible into shares of common stock of the Company at an initial conversion price of $0.001, except that, if the Company failed to repay the debenture upon maturity, the conversion price would be reduced to $0.0004 (subject to adjustment for stock splits, stock dividends, and similar transactions) and the debenture would bear interest at the rate of 9% per year. The Company’s obligation to repay the debenture upon maturity was initially secured by a security interest in the Company’s inventory pursuant to a security agreement between the Company and the investor. For the year ended August 31, 2020 the Company recorded amortization of debt discount of $500,000. A portion of the debenture was subsequently sold by the original purchaser to a third party. On April 23, 2020, the Company entered into an amendment to the security agreement with the holders of the debentures. Pursuant to the security agreement amendment, the collateral under the security agreement was amended to be the Company’s URLs. The Company has also entered into five amendments to the debentures to extend the maturity date, including, most recently, an amendment entered into on August 2, 2021, to extend the maturity date to August 31, 2021.


XML 20 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Equity
9 Months Ended
May 31, 2021
Stockholders' Equity Note [Abstract]  
EQUITY

5. EQUITY


Common Stock and Preferred Stock


As of August 31, 2020, the Company had authorized capital of 800,000,000 shares of common stock with a par value of $0.001, and 50,000,000 shares of preferred stock with a par value of $0.001. On October 2, 2020, the Company filed a certificate of amendment to the Company’s articles of incorporation with the Secretary of State of Nevada, pursuant to which the Company increased its authorized shares of common stock from 800,000,000 to 3,000,000,000. 1,000 shares of preferred stock are designated as Series A Convertible Preferred Stock. No shares of Series A Preferred Stock are issued and outstanding as of August 31, 2020 and May 31, 2021 respectively. The Company’s Certificate of Designation of Series B Preferred Stock was withdrawn by the Company on June 30, 2020. 1 share of preferred stock is designated Series C Preferred Stock and is issued and outstanding as of August 31, 2020 and May 31, 2021, respectively. The Series C Preferred Stock has a stated value of $24,000 and entitles the holder to 51% of the total voting power of the Company’s stockholders. The Company may, in its sole discretion, redeem the Series C Preferred Stock at any time for a redemption price equal to the stated value. Upon payment of the redemption price by the Company, the Series C Preferred Stock will revert to the status of authorized but unissued preferred stock.


Pursuant to a securities purchase agreement entered into on June 6, 2018 the Company was obligated to issue additional shares of common stock if the Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser would be equal to $50,000 divided by lower financing price. As of August 31, 2020, the Company was obligated to issue 500,000 shares of common stock valued at $76,000. On January 5, 2021, the Company issued the 500,000 shares of common stock.


On August 31, 2020, the Company issued a promissory note in the principal amount of $150,000, to Danil Pollack, the Company’s chief executive officer. $120,000 was remitted upon execution of the note and the remaining $30,000 was remitted on September 22, 2020. The note did not bear interest. On November 10, 2020, the Company entered into an exchange agreement with Mr. Pollack. Pursuant to the exchange agreement, Mr. Pollack exchanged the promissory note for 15,000,000 shares of common stock of the Company.


During the nine months ended May 31, 2021, Mr. Pollack loaned the Company an additional $100,534 that was non-interest bearing and payable upon demand. $100,000 of this amount was subsequently deemed to be consideration for 5,000,000 shares of common stock the Company issued to Mr. Pollack on January 6, 2021.


On November 30, 2020, the Company entered into a securities purchase agreement with Danil Pollack. Pursuant to the purchase agreement, the Company issued and sold to Mr. Pollack 20,000,000 shares of common stock for an aggregate purchase price of $200,000.


On January 21, 2021, the Company entered into a securities purchase agreement with Danil Pollack. Pursuant to the purchase agreement, the Company issued and sold to Mr. Pollack 2,000,000 shares of common stock for an aggregate purchase price of $100,000.


On February 24, 2021, the Company entered into a securities purchase agreement with an accredited investor. Pursuant to the purchase agreement, the Company issued and sold to the investor 10,000,000 shares of common stock for an aggregate purchase price of $500,000.


Warrants 


The following table summarizes the warrant activities during the nine months ended May 31, 2021:


   Number of
Warrants
   Weighted-
Average
Price Per
Share
   Weighted-
Average
Remaining
Life
 
Outstanding at August 31, 2020   3,450,000   $0.56   2.8 years 
Granted   -    -     
Canceled or expired   (450,000)   0.81     
Exercised   -    -     
Outstanding at May 31, 2021   3,000,000   $0.52   2.41 years 
Exercisable at May 31, 2021   3,000,000   $0.52   2.41 years 
Intrinsic value at May 31, 2021       $-     

Options


On April 21, 2020, Danil Pollack was appointed president, chief executive officer, and chief financial officer of the Company. In connection with Mr. Pollack’s appointment, the Company entered into an employment agreement with Mr. Pollack. Pursuant to the employment agreement, Mr. Pollack will serve as the Company’s chief executive officer and president for a period of one year, which term will renew automatically for successive one year terms, subject to the right of either party to terminate the agreement at any time upon written notice. Mr. Pollack was granted the right, for a period of six months, to purchase up to 100,000,000 shares of common stock of the Company for a purchase price of $0.001 per share. The Company recognized option expense of $1,416,975 during the year ended August 31, 2020. During the year ended August 31, 2020, Mr. Pollack exercised 84,000,000 stock options for $84,000. During the nine months ended May 31, 2021, the remaining 16,000,000 stock options expired.


The following table summarizes the option activities during the nine months ended May 31, 2021:


   Number of
Options
   Weighted-
Average
Price Per
Share
   Weighted-
Average
Remaining
Life
 
Outstanding at August 31, 2020   16,000,000   $.001   0.9 years 
Granted   -    -     
Canceled or expired   (16,000,000)   .001     
Exercised   -    -     
Outstanding at May 31, 2021   -   $-     
Exercisable at May 31, 2021   -   $-     

XML 21 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions
9 Months Ended
May 31, 2021
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

6. RELATED PARTY TRANSACTIONS


On September 30, 2020, the Company entered into an amendment to the Company’s employment agreement, dated April 22, 2020, with Danil Pollack, the Company’s chief executive officer. Pursuant to the amendment, the Company will pay Mr. Pollack an annual salary of $48,000. The Company may also in its discretion pay additional compensation to Mr. Pollack at any time as a bonus. On April 27, 2021, the Company entered into an amendment to the Company’s employment agreement with Mr. Pollack. Pursuant to the amendment, the Company will pay Mr. Pollack an annual salary of $66,000 effective April 1, 2021. The Company may also in its discretion pay additional compensation to Mr. Pollack at any time as a bonus.


On August 31, 2020, the Company issued a promissory note in the principal amount of $150,000, to Danil Pollack. $120,000 was remitted upon execution of the note and the remaining $30,000 was paid on September 22, 2020. The note did not bear interest. On November 10, 2020, the Company entered into an exchange agreement with Mr. Pollack. Pursuant to the exchange agreement, Mr. Pollack exchanged this note for 15,000,000 shares of common stock of the Company.


During the nine months ended May 31, 2021, Mr. Pollack loaned the Company an additional $100,534 that was non-interest bearing and payable upon demand. $100,000 of this amount was subsequently deemed to be consideration for 5,000,000 shares of common stock the Company issued to Mr. Pollack on January 6, 2021.


On November 30, 2020, the Company entered into a securities purchase agreement with Mr. Pollack. Pursuant to the purchase agreement, the Company issued and sold to Mr. Pollack 20,000,000 shares of common stock for an aggregate purchase price of $200,000.


On January 21, 2021, the Company entered into a securities purchase agreement with Danil Pollack. Pursuant to the purchase agreement, the Company issued and sold to Mr. Pollack 2,000,000 shares of common stock for an aggregate purchase price of $100,000.


XML 22 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies
9 Months Ended
May 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

7. COMMITMENTS AND CONTINGENCIES


Pursuant to a securities purchase agreement entered into on June 6, 2018 the Company was obligated to issue additional shares of common stock if the Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser would be equal to $50,000 divided by lower financing price. As of November 30, 2020 and August 31, 2020, the Company was obligated to issue 500,000 shares of common stock valued at $76,000 which is included in the common stock payable in the accompanying balance sheet. On January 5, 2021, the Company issued 500,000 shares of common stock.


On April 21, 2020, Danil Pollack was appointed president, chief executive officer, and chief financial officer of the Company. In connection with Mr. Pollack’s appointment, the Company entered into an employment agreement with Mr. Pollack. On September 30, 2020, the Company entered into an amendment to the employment agreement. Pursuant to the amendment, the Company will pay Mr. Pollack an annual salary of $48,000. The Company may also in its discretion pay additional compensation to Mr. Pollack at any time as a bonus. On April 27, 2021, the Company entered into an amendment to the Company’s employment agreement with Mr. Pollack. Pursuant to the amendment, the Company will pay Mr. Pollack an annual salary of $66,000 effective April 1, 2021. The Company may also in its discretion pay additional compensation to Mr. Pollack at any time as a bonus.


On October 13, 2020, the Company entered into a consulting agreement with Yaniv Rozen pursuant to which the Company engaged Mr. Rozen to serve as the Company’s chief operating officer on a consultant/independent contractor basis. Mr. Rozen was permitted to engage in other business activities while serving as the Company’s chief operating officer. On July 1, 2021, Yaniv Rozen resigned as chief operating officer of the Company.


Pursuant to the consulting agreement, the Company agreed to pay Mr. Rozen a fee of $3,000 per month.


The Company also agreed to issue to Mr. Rozen shares of common stock, and increase such monthly fee, as follows:


  Within five business day of the end of the fourth quarter of 2020, (i) if the Company’s average sales were at least $50,000 per month, for such quarter, the Company would issue to Mr. Rozen 500,000 shares of common stock; or (ii) if the Company’s average sales were at least $100,000 per month for such quarter, the Company would issue to Mr. Rozen 750,000 shares of common stock;

  Within five business day of the end of the first quarter of 2021, (i) if the Company’s average sales were at least $100,000 per month for such quarter, the Company would issue to Mr. Rozen 750,000 shares of common stock, or (ii) if the Company’s average sales were at least $150,000 per month for such quarter, the Company would issue to Mr. Rozen 1,000,000 shares of common stock, and would increase Mr. Rozen’s fee to $5,000 per month effective commencing at the end such quarter;

  Within five business days of the end of the second quarter of 2021, (i) if the Company’s average sales were at least $200,000 per month, for such quarter, the Company would issue to Mr. Rozen 1,500,000 shares of common stock, or (ii) if the Company’s average sales were at least $300,000 per month, for such quarter, the Company would issue to Mr. Rozen 2,000,000 shares of common stock; and

  Within five business days of the end of the third quarter of 2021, (i) if the Company’s average sales were at least $300,000 per month, for such quarter, the Company would issue to Mr. Rozen 2,000,000 shares of common stock; or (ii) if the Company’s average sales were at least $500,000 per month, for such quarter, the Company would issue to Mr. Rozen 3,000,000 shares of common stock, and would increase Mr. Rozen’s fee to $7,000 per month effective commencing at the end such quarter.

As of July 1, 2021, Mr. Rozen’s resignation date, there was no common stock owed to Mr. Rozen as the quarterly target sales were not met.


The COVID-19 pandemic may negatively affect our operations, including by limiting access to our facilities, customers, management, and professional advisors, and causing delays and constraints in manufacturing and shipping of our products. These factors, in turn, may negatively impact our operations, financial condition and demand for our products, and our ability to raise capital on acceptable terms, or at all.


XML 23 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Major Customers
9 Months Ended
May 31, 2021
Risks and Uncertainties [Abstract]  
MAJOR CUSTOMERS

8. MAJOR CUSTOMERS


At May 31, 2021 and August 31, 2020, no individual customer amounted to over 10% of total accounts receivable. During the three and nine months ended May 31, 2021 and May 31, 2020 no individual customer amounted to over 10% of total sales. 


XML 24 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events
9 Months Ended
May 31, 2021
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

9. SUBSEQUENT EVENTS 


On July 1, 2021, Yaniv Rozen resigned as chief operating officer of the Company. See Note 7.


On August 2, 2021, the Company entered into amendments (“Amendment No. 6”) with the holders of the Company’s original issue discount convertible debentures, with an original issuance date of December 24, 2019, as amended by amendment No. 1 thereto, dated May 28, 2020, amendment No. 2 thereto, dated August 21, 2020, amendment No. 3 thereto, dated December 10, 2020, Amendment No. 4 thereto, dated January 15, 2021, and Amendment No. 5 thereto, dated April 2, 2021, in the aggregate outstanding principal amount of $500,000. Pursuant to Amendment No. 6, the maturity date of the debentures was extended to August 31, 2021.


XML 25 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Accounting Policies, by Policy (Policies)
9 Months Ended
May 31, 2021
Accounting Policies [Abstract]  
Nature of Business Operations

Nature of Business Operations


Bespoke Extracts, Inc. (the “Company”) is a Nevada corporation focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products.


The Company introduced its original line of CBD products in 2018. In the fall of 2020, the Company unveiled a new brand image, new website and ecommerce store and a new line-up of hemp-derived CBD formulations available for purchase in the form of tinctures, softgels and creams.

Basis of Presentation

Basis of Presentation


The accompanying condensed unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments consisting of a normal and recurring nature considered necessary for a fair presentation have been included. Operating results for the three and nine months ended May 31, 2021 may not necessarily be indicative of the results that may be expected for the year ended August 31, 2021.


For further information, refer to the Company’s financial statements and footnotes thereto included in the Annual Report on Form 10-K for the year ended August 31, 2020.


Certain prior period amounts have been reclassified to conform to the current period presentation.

Going Concern

Going Concern


The accompanying condensed financial statements have been prepared assuming a continuation of the Company as a going concern. The Company had negative cash flows from operations, a working capital deficit and an accumulated deficit as of and for the nine months ended May 31, 2021. This raises substantial doubt about our ability to continue as a going concern.


The Company’s ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repaying its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed.


Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we will have to curtail or cease our operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. These financial statements do not include any adjustments that might arise from this uncertainty.

Use of Estimates

Use of Estimates


The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements and accompanying notes. Significant estimates include the assumption used in the valuation of equity-based transactions, valuation of intangible assets, allowance for doubtful accounts and inventory valuation and reserves. Actual results could differ from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents


Cash and cash equivalents include all highly liquid investments with original maturities of three months or less at the time of purchase. At May 31, 2021 and August 31, 2020, the Company did not have any cash equivalents.

Fair Value of Financial Instruments

Fair Value of Financial Instruments


The carrying amounts of cash, accounts receivable, prepaid expenses, inventory and other assets, accounts payable, accrued liabilities, note payable and convertible note payable approximate their fair values as of May 31, 2021 and August 31, 2020, respectively, because of their short-term natures and the Company’s borrowing rate of interest.

Accounts Receivable

Accounts Receivable


Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased bad debt expense.


The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30 or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging off uncollectible receivables is made. At May 31, 2021 and August 31, 2020, the Company has recorded an allowance for doubtful accounts of $2,981 and $2,981, respectively. At May 31, 2021 and August 31, 2020 included in the accounts receivable is the merchant holdback receivable balance of $3,636 and $3,585, respectively which will be remitted to the Company in the future.

Inventory

Inventory


Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of May 31, 2021 and August 31, 2020, inventory amounted to $76,857 and $0, respectively, which consisted of finished goods of $72,435, and raw materials of $4,422 net of reserves. During the nine months ended May 31, 2021 the Company adjusted the reserves by $6,776 for products sold. As of May 31, 2021 and August 31, 2020 inventory reserves were $33,476 and $40,252, respectively.

Revenue Recognition

Revenue Recognition


We account for revenue in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification Topic 606, “Revenue from Contracts with Customers”. Revenue is measured based on the amount of consideration that we expect to receive, reduced by discounts and estimates for credits and returns (calculated based upon previous experience and management’s evaluation). Outbound shipping charged to customers is recognized at the time the related merchandise revenues are recognized and are included in net revenues. Inbound and outbound shipping and delivery costs are included in cost of revenues.


Our products are sold through our online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due on the date of shipment. The Company offers a 30 day return policy on sales.

Stock Option Plans

Stock Option Plans


Stock options and warrants issued to consultants and other non-employees as compensation for services provided to the Company are accounted for based on the fair value of the services provided or the estimated fair market value of the option or warrant, whichever is more reliably measurable, and in accordance FASB ASC 718, Compensation-Stock Compensation, including related amendments and interpretations. The related expense is recognized over the period the services are provided. Stock option compensation expense has been recognized as a component of general and administrative expenses in the accompanying financial statements for the three and nine months ended May 31, 2020. No stock option compensation expense was recognized for the three and nine months ended May 31, 2021.

Net Income / (Loss) per Share

Net Income / (Loss) per Share


Basic income / (loss) per share amounts are computed based on net income / (loss) divided by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if potentially dilutive securities were exercised or converted to common stock. The dilutive effect of options and warrants and their equivalent is computed by application of the treasury stock method and the effect of convertible securities by the “if converted” method. The effect of 3,000,000 warrants and 0 options as well as 500,000,000 shares issuable upon the conversion of a convertible note are anti-dilutive for the three and nine months ended May 31, 2021. The effect of 3,450,000 warrants and 81,200,000 options is anti-dilutive for the three and nine months end May 31, 2020.

XML 26 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Equity (Tables)
9 Months Ended
May 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of warrants
   Number of
Warrants
   Weighted-
Average
Price Per
Share
   Weighted-
Average
Remaining
Life
 
Outstanding at August 31, 2020   3,450,000   $0.56   2.8 years 
Granted   -    -     
Canceled or expired   (450,000)   0.81     
Exercised   -    -     
Outstanding at May 31, 2021   3,000,000   $0.52   2.41 years 
Exercisable at May 31, 2021   3,000,000   $0.52   2.41 years 
Intrinsic value at May 31, 2021       $-     
Schedule of stock options
   Number of
Options
   Weighted-
Average
Price Per
Share
   Weighted-
Average
Remaining
Life
 
Outstanding at August 31, 2020   16,000,000   $.001   0.9 years 
Granted   -    -     
Canceled or expired   (16,000,000)   .001     
Exercised   -    -     
Outstanding at May 31, 2021   -   $-     
Exercisable at May 31, 2021   -   $-     
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Nature of Operations, Significant Accounting Policies and Going Concern (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
May 31, 2021
May 31, 2021
Aug. 31, 2020
Aug. 31, 2021
Nature of Operations, Significant Accounting Policies and Going Concern (Details) [Line Items]        
Allowance for doubtful accounts $ 2,981 $ 2,981 $ 2,981  
Inventory   3,636 3,585  
Inventory, net 76,857 76,857 $ 0
Inventory finished goods 72,435 72,435    
Raw material, net reserve     4,422  
Adjusted reserves 6,776 6,776    
Inventory $ 33,476 $ 33,476 $ 40,252  
Anti-dilutive shares of warrants and options (in Shares) 3,450,000 81,200,000    
Shares issuable conversion of a convertible note (in Shares)   500,000,000    
Warrant [Member]        
Nature of Operations, Significant Accounting Policies and Going Concern (Details) [Line Items]        
Anti-dilutive shares of warrants and options (in Shares) 3,000,000      
Options [Member]        
Nature of Operations, Significant Accounting Policies and Going Concern (Details) [Line Items]        
Anti-dilutive shares of warrants and options (in Shares)   0    
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Asset Purchase Agreement (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
May 31, 2021
May 31, 2020
May 31, 2021
May 31, 2020
Aug. 31, 2020
Feb. 21, 2017
Asset Purchase Agreement [Abstract]            
Total approximate amount include in asset purchase agreement           $ 20,185
Number of common stock (in Shares)           200,000
Common stock value           $ 30,000
Transferred certain URLs values to holder         $ 5,282  
Impairment expense         289  
Repaid of note holder         $ 44,614  
Amortized over period         15 years  
Amortization expense $ 811 $ 811 $ 2,433 $ 2,508    
Impairment expense     $ 289      
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Note Payable - Related Party (Details) - USD ($)
12 Months Ended
Jan. 06, 2021
Aug. 31, 2020
May 31, 2021
Debt Disclosure [Abstract]      
Principal amount   $ 150,000  
Related party, description   the Company’s chief executive officer. $120,000 was remitted upon execution of the note and the remaining $30,000 was remitted on September 22, 2020. The note did not bear interest. On November 10, 2020, the Company entered into an exchange agreement with Mr. Pollack. Pursuant to the exchange agreement, Mr. Pollack exchanged the note for 15,000,000 shares of common stock of the Company.  
Non-interest bearing payable     $ 100,534
Issued amount $ 100,000    
Common stock issued (in Shares) 5,000,000    
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Convertible Note Payable (Details) - USD ($)
1 Months Ended 12 Months Ended
Dec. 24, 2019
Aug. 31, 2020
Convertible Note Payable (Details) [Line Items]    
Principal amount $ 500,000  
Purchase amount $ 300,000  
Conversion per value (in Dollars per share) $ 0.005  
Beneficial conversion feature $ 245,000  
Maturity date Apr. 30, 2020  
Conversion price (in Dollars per share) $ 0.001  
Conversion price reduced per share (in Dollars per share) $ 0.0004  
Bear interest rate 9.00%  
Conversion rate, description more than 4.99%  
Securities Purchase Agreement [Member]    
Convertible Note Payable (Details) [Line Items]    
Amortization of debt discount   $ 500,000
Investor [Member]    
Convertible Note Payable (Details) [Line Items]    
Issuance of common shares (in Shares) 5,000,000  
Common stock value $ 55,000  
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Equity (Details) - USD ($)
1 Months Ended 9 Months Ended
Jan. 06, 2021
Oct. 02, 2020
Apr. 21, 2020
Jun. 06, 2018
Feb. 24, 2021
Jan. 21, 2021
Nov. 30, 2020
Aug. 31, 2020
May 31, 2021
Jan. 05, 2021
Equity (Details) [Line Items]                    
Common stock, shares authorized (in Shares)               800,000,000    
Common stock, par value (in Dollars per share)               $ 0.001 $ 0.001  
Preferred stock, shares authorized (in Shares)               50,000,000 50,000,000  
Preferred stock, par value (in Dollars per share)               $ 0.001 $ 0.001  
Description of stock   On October 2, 2020, the Company filed a certificate of amendment to the Company’s articles of incorporation with the Secretary of State of Nevada, pursuant to which the Company increased its authorized shares of common stock from 800,000,000 to 3,000,000,000. 1,000 shares of preferred stock are designated as Series A Convertible Preferred Stock.                
Debt instrument, annual principal amount               $ 150,000    
Remitted value               $ 120,000    
Additional amount                 $ 100,534  
Amount deemed consideration $ 100,000               $ 100,000  
Common stock share issued (in Shares) 5,000,000           500,000   5,000,000 500,000
Common stock aggregate shares (in Shares)         10,000,000 2,000,000 20,000,000      
Common stock aggregate amount         $ 500,000 $ 100,000 $ 200,000      
Securities Purchase Agreement [Member]                    
Equity (Details) [Line Items]                    
Common stock share issued (in Shares)               500,000    
Investor [Member] | Securities Purchase Agreement [Member]                    
Equity (Details) [Line Items]                    
Description of common stock       on June 6, 2018 the Company was obligated to issue additional shares of common stock if the Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser would be equal to $50,000 divided by lower financing price. As of August 31, 2020, the Company was obligated to issue 500,000 shares of common stock valued at $76,000. On January 5, 2021, the Company issued the 500,000 shares of common stock.            
Series C Preferred Stock [Member]                    
Equity (Details) [Line Items]                    
Preferred stock, par value (in Dollars per share)               $ 0.001 $ 0.001  
Holder voting power, description                 The Series C Preferred Stock has a stated value of $24,000 and entitles the holder to 51% of the total voting power of the Company’s stockholders.  
Series B Preferred Stock [Member]                    
Equity (Details) [Line Items]                    
Letter agreement, description               upon execution of the note and the remaining $30,000 was remitted on September 22, 2020. The note did not bear interest. On November 10, 2020, the Company entered into an exchange agreement with Mr. Pollack. Pursuant to the exchange agreement, Mr. Pollack exchanged the promissory note for 15,000,000 shares of common stock of the Company.    
Options [Member] | Danil Pollack [Member]                    
Equity (Details) [Line Items]                    
Employment agreement, description     Pursuant to the employment agreement, Mr. Pollack will serve as the Company’s chief executive officer and president for a period of one year, which term will renew automatically for successive one year terms, subject to the right of either party to terminate the agreement at any time upon written notice. Mr. Pollack was granted the right, for a period of six months, to purchase up to 100,000,000 shares of common stock of the Company for a purchase price of $0.001 per share. The Company recognized option expense of $1,416,975 during the year ended August 31, 2020. During the year ended August 31, 2020, Mr. Pollack exercised 84,000,000 stock options for $84,000. During the nine months ended May 31, 2021, the remaining 16,000,000 stock options expired.              
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Equity (Details) - Schedule of warrants - Warrants [Member]
9 Months Ended
May 31, 2021
USD ($)
$ / shares
shares
Class of Warrant or Right [Line Items]  
Number of Warrants, Outstanding Beginning balance | shares 3,450,000
Weighted-Average Price Per Share, Outstanding Beginning balance | $ / shares $ 0.56
Weighted-Average Remaining Life, Outstanding Beginning years 2 years 292 days
Number of Warrants, Granted | shares
Weighted-Average Price Per Share, Granted | $ / shares
Number of Warrants, Canceled or expired | shares (450,000)
Weighted-Average Price Per Share, Canceled or expired | $ / shares $ 0.81
Number of Warrants, Exercised | shares
Weighted-Average Price Per Share, Exercised | $ / shares
Number of Warrants, Outstanding Ending balance | shares 3,000,000
Weighted-Average Price Per Share, Outstanding Ending balance | $ / shares $ 0.52
Weighted-Average Remaining Life, Outstanding Ending years 2 years 149 days
Number of Warrants, Exercisable | shares 3,000,000
Weighted-Average Price Per Share, Exercisable | $ / shares $ 0.52
Weighted-Average Remaining Life, Exercisable 2 years 149 days
Weighted-Average Price Per Share Intrinsic value | $
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Equity (Details) - Schedule of stock options - Options [Member]
9 Months Ended
May 31, 2021
$ / shares
shares
Equity (Details) - Schedule of stock options [Line Items]  
Number of Options, Outstanding Beginning balance | shares 16,000,000
Weighted-Average Price Per Share, Outstanding Beginning balance | $ / shares $ 0.001
Weighted-Average Remaining Life, Outstanding Beginning years 328 days
Number of Options, Granted | shares
Weighted-Average Price Per Share, Granted | $ / shares
Number of Options, Canceled or expired | shares (16,000,000)
Weighted-Average Price Per Share, Canceled or expired | $ / shares $ 0.001
Number of Options, Exercised | shares
Weighted-Average Price Per Share, Exercised | $ / shares
Number of Options, Outstanding Ending balance | shares
Weighted-Average Price Per Share, Outstanding Ending balance | $ / shares
Number of Options, Exercisable | shares
Weighted-Average Price Per Share, Exercisable | $ / shares
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions (Details) - USD ($)
1 Months Ended 6 Months Ended 9 Months Ended
Jan. 06, 2021
Apr. 30, 2021
Jan. 21, 2021
Nov. 30, 2020
Sep. 30, 2020
Aug. 31, 2020
Nov. 30, 2020
May 31, 2021
Jan. 05, 2021
Nov. 10, 2020
Related Party Transactions (Details) [Line Items]                    
Mr. Pollack an annual salary   $ 66,000     $ 48,000          
Outstanding shares (in Shares)                   15,000,000
Non-interest bearing payable             $ 100,534      
Amount deemed consideration $ 100,000             $ 100,000    
Issued amount (in Shares) 5,000,000     500,000     500,000 5,000,000 500,000  
Common stock aggregate shares (in Shares)     2,000,000 20,000,000            
Common stock aggregate purchase price     $ 100,000 $ 200,000            
Employment Agreement [Member]                    
Related Party Transactions (Details) [Line Items]                    
Promissory note, description           the Company issued a promissory note in the principal amount of $150,000, to Danil Pollack. $120,000 was remitted upon execution of the note and the remaining $30,000 was paid on September 22, 2020.        
Chief Executive Officer [Member]                    
Related Party Transactions (Details) [Line Items]                    
Letter agreement, description           Pursuant to the exchange agreement, Mr. Pollack exchanged this note for 15,000,000 shares of common stock of the Company.        
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies (Details)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Apr. 01, 2021
USD ($)
Oct. 13, 2020
USD ($)
Sep. 30, 2020
USD ($)
Jun. 06, 2018
USD ($)
$ / shares
Nov. 30, 2021
USD ($)
shares
May 31, 2021
USD ($)
shares
Feb. 28, 2021
USD ($)
shares
Aug. 31, 2020
USD ($)
shares
May 31, 2020
USD ($)
May 31, 2021
USD ($)
shares
May 31, 2020
USD ($)
Aug. 31, 2019
USD ($)
Jan. 06, 2021
shares
Jan. 05, 2021
shares
Nov. 30, 2020
shares
Commitments and Contingencies (Details) [Line Items]                              
Common stock issued (in Shares) | shares           5,000,000       5,000,000     5,000,000 500,000 500,000
Mr. Pollack an annual salary $ 66,000                            
Fees           $ 22,604     $ 25,367 $ 85,227 $ 174,153        
Business days           5                  
Professional Fee           $ 7,000                  
Securities Purchase Agreement [Member]                              
Commitments and Contingencies (Details) [Line Items]                              
Common stock per share (in Dollars per share) | $ / shares       $ 0.10                      
Exercise price (in Dollars per share) | $ / shares       $ 0.10                      
Dividend       $ 50,000                      
Common stock issued (in Shares) | shares               500,000              
Value of common stock                       $ 76,000      
Mr. Pollack an annual salary     $ 48,000                        
Minimum [Member]                              
Commitments and Contingencies (Details) [Line Items]                              
Monthly average sales           $ 300,000 $ 200,000 $ 50,000              
Minimum [Member] | Subsequent Event [Member]                              
Commitments and Contingencies (Details) [Line Items]                              
Monthly average sales         $ 100,000                    
Maximum [Member]                              
Commitments and Contingencies (Details) [Line Items]                              
Common stock issued (in Shares) | shares           750,000       750,000          
Monthly average sales           $ 500,000 $ 300,000     $ 100,000          
Maximum [Member] | Subsequent Event [Member]                              
Commitments and Contingencies (Details) [Line Items]                              
Monthly average sales         150,000                    
Consulting Agreement [Member]                              
Commitments and Contingencies (Details) [Line Items]                              
Fees   $ 3,000                          
Mr. Rozen [Member] | Subsequent Event [Member]                              
Commitments and Contingencies (Details) [Line Items]                              
Fees         $ 5,000                    
Mr. Rozen [Member] | Minimum [Member]                              
Commitments and Contingencies (Details) [Line Items]                              
Common stock issued (in Shares) | shares           2,000,000 1,500,000 500,000   2,000,000          
Mr. Rozen [Member] | Minimum [Member] | Subsequent Event [Member]                              
Commitments and Contingencies (Details) [Line Items]                              
Common stock issued (in Shares) | shares         750,000                    
Mr. Rozen [Member] | Maximum [Member]                              
Commitments and Contingencies (Details) [Line Items]                              
Common stock issued (in Shares) | shares           3,000,000 2,000,000     3,000,000          
Mr. Rozen [Member] | Maximum [Member] | Subsequent Event [Member]                              
Commitments and Contingencies (Details) [Line Items]                              
Common stock issued (in Shares) | shares         1,000,000                    
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Major Customers (Details)
1 Months Ended 3 Months Ended 9 Months Ended
May 31, 2021
Aug. 31, 2020
May 31, 2021
May 31, 2021
Major Customers (Details) [Line Items]        
Number of individual customer     0 0
Concentration risk percentage     10.00% 10.00%
Accounts Receivables [Member]        
Major Customers (Details) [Line Items]        
Number of individual customer 0      
Concentration risk percentage   10.00%    
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events (Details)
9 Months Ended
May 31, 2021
USD ($)
Subsequent Events [Abstract]  
Aggregate principal amount $ 500,000
EXCEL 38 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 39 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 40 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 41 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 132 300 1 false 24 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.bespokeextracts.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Balance Sheets Sheet http://www.bespokeextracts.com/role/ConsolidatedBalanceSheet Condensed Balance Sheets Statements 2 false false R3.htm 002 - Statement - Condensed Balance Sheets (Parentheticals) Sheet http://www.bespokeextracts.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Statements of Operations (Unaudited) Sheet http://www.bespokeextracts.com/role/ConsolidatedIncomeStatement Condensed Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Statement of Stockholders Deficit Sheet http://www.bespokeextracts.com/role/ShareholdersEquityType2or3 Condensed Statement of Stockholders Deficit Statements 5 false false R6.htm 005 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://www.bespokeextracts.com/role/ConsolidatedCashFlow Condensed Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Nature of Operations, Significant Accounting Policies and Going Concern Sheet http://www.bespokeextracts.com/role/NatureofOperationsSignificantAccountingPoliciesandGoingConcern Nature of Operations, Significant Accounting Policies and Going Concern Notes 7 false false R8.htm 007 - Disclosure - Asset Purchase Agreement Sheet http://www.bespokeextracts.com/role/AssetPurchaseAgreement Asset Purchase Agreement Notes 8 false false R9.htm 008 - Disclosure - Note Payable - Related Party Sheet http://www.bespokeextracts.com/role/NotePayableRelatedParty Note Payable - Related Party Notes 9 false false R10.htm 009 - Disclosure - Convertible Note Payable Sheet http://www.bespokeextracts.com/role/ConvertibleNotePayable Convertible Note Payable Notes 10 false false R11.htm 010 - Disclosure - Equity Sheet http://www.bespokeextracts.com/role/Equity Equity Notes 11 false false R12.htm 011 - Disclosure - Related Party Transactions Sheet http://www.bespokeextracts.com/role/RelatedPartyTransactions Related Party Transactions Notes 12 false false R13.htm 012 - Disclosure - Commitments and Contingencies Sheet http://www.bespokeextracts.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 13 false false R14.htm 013 - Disclosure - Major Customers Sheet http://www.bespokeextracts.com/role/MajorCustomers Major Customers Notes 14 false false R15.htm 014 - Disclosure - Subsequent Events Sheet http://www.bespokeextracts.com/role/SubsequentEvents Subsequent Events Notes 15 false false R16.htm 015 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.bespokeextracts.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://www.bespokeextracts.com/role/NatureofOperationsSignificantAccountingPoliciesandGoingConcern 16 false false R17.htm 016 - Disclosure - Equity (Tables) Sheet http://www.bespokeextracts.com/role/EquityTables Equity (Tables) Tables http://www.bespokeextracts.com/role/Equity 17 false false R18.htm 017 - Disclosure - Nature of Operations, Significant Accounting Policies and Going Concern (Details) Sheet http://www.bespokeextracts.com/role/NatureofOperationsSignificantAccountingPoliciesandGoingConcernDetails Nature of Operations, Significant Accounting Policies and Going Concern (Details) Details 18 false false R19.htm 018 - Disclosure - Asset Purchase Agreement (Details) Sheet http://www.bespokeextracts.com/role/AssetPurchaseAgreementDetails Asset Purchase Agreement (Details) Details http://www.bespokeextracts.com/role/AssetPurchaseAgreement 19 false false R20.htm 019 - Disclosure - Note Payable - Related Party (Details) Sheet http://www.bespokeextracts.com/role/NotePayableRelatedPartyDetails Note Payable - Related Party (Details) Details http://www.bespokeextracts.com/role/NotePayableRelatedParty 20 false false R21.htm 020 - Disclosure - Convertible Note Payable (Details) Sheet http://www.bespokeextracts.com/role/ConvertibleNotePayableDetails Convertible Note Payable (Details) Details http://www.bespokeextracts.com/role/ConvertibleNotePayable 21 false false R22.htm 021 - Disclosure - Equity (Details) Sheet http://www.bespokeextracts.com/role/EquityDetails Equity (Details) Details http://www.bespokeextracts.com/role/EquityTables 22 false false R23.htm 022 - Disclosure - Equity (Details) - Schedule of warrants Sheet http://www.bespokeextracts.com/role/ScheduleofwarrantsTable Equity (Details) - Schedule of warrants Details http://www.bespokeextracts.com/role/EquityTables 23 false false R24.htm 023 - Disclosure - Equity (Details) - Schedule of stock options Sheet http://www.bespokeextracts.com/role/ScheduleofstockoptionsTable Equity (Details) - Schedule of stock options Details http://www.bespokeextracts.com/role/EquityTables 24 false false R25.htm 024 - Disclosure - Related Party Transactions (Details) Sheet http://www.bespokeextracts.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.bespokeextracts.com/role/RelatedPartyTransactions 25 false false R26.htm 025 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.bespokeextracts.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.bespokeextracts.com/role/CommitmentsandContingencies 26 false false R27.htm 026 - Disclosure - Major Customers (Details) Sheet http://www.bespokeextracts.com/role/MajorCustomersDetails Major Customers (Details) Details http://www.bespokeextracts.com/role/MajorCustomers 27 false false R28.htm 027 - Disclosure - Subsequent Events (Details) Sheet http://www.bespokeextracts.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.bespokeextracts.com/role/SubsequentEvents 28 false false All Reports Book All Reports bspk-20210531.xml bspk-20210531.xsd bspk-20210531_cal.xml bspk-20210531_def.xml bspk-20210531_lab.xml bspk-20210531_pre.xml http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021 http://fasb.org/srt/2021-01-31 true true ZIP 43 0001213900-21-043396-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-21-043396-xbrl.zip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